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ABSTRACT 
Dementia is a syndrome that afflicts older persons and is characterized by progressive 
deterioration in memory and other cognitive functions, behavior, and the ability to perform 
day-to-day activities. Older adults, and even more so those suffering from dementia, often 
experience disturbances in the sleep-wake cycle. This thesis sought to investigate the long-
term effect of sleep and shift work (SW), which can affect sleep patterns and sleep quality, 
in dementia and cognitive aging using prospective and longitudinal studies of the Swedish 
Twin Registry (STR).  
Study I  prospectively explored whether sleep characteristics such as time in bed (TIB), 
rising time, bedtime, sleep quality, non-restorative sleep, and snoring in late life were 
associated with dementia incidence while accounting for baseline cognitive functioning. 
The study was based on a sample of 11,247 participants aged 65 and older. Short (≤6 
hours) and extended (>9 hours) TIB as well as late rising time (rising 8:00 AM or later) 
were associated with higher dementia incidence in the following 17 years. After stratifying 
by baseline cognitive status, only the association between short TIB and dementia 
remained in those cognitively intact at baseline. Altogether, the findings suggest that 
extended TIB and late rising represent prodromal features whereas short TIB appeared to 
be a risk factor for dementia. 
Study II employed quantitative genetic methods to investigate the relative importance of 
genetic influences for late-life sleep characteristics, dementia and Alzheimer’s disease (AD), 
and whether dementia-related sleep characteristics modified genetic influences on 
dementia and AD in a sample of 10,894 twins. Genetic influences accounted for about half 
of the variation in liability to dementia and AD, and for late rise time and bedtime. For the 
other sleep phenotypes assessed, non-shared environment contributed a larger part of the 
phenotypic variation. TIB and late rising were associated with dementia incidence, but 
these sleep traits did not moderate the genetic influences on dementia and AD.   
Study III examined the association between SW and dementia incidence. The study was 
based on two cohorts: one cohort comprised 13,283 individuals with information on any-
type SW and another cohort comprised 41,199 individuals with information on night work 
(NW), with follow-up time spanning 41 and 14 years, respectively. History of SW, including 
NW, was associated with higher dementia incidence. Further, longer duration of SW and 
NW appeared to be associated with greater risk of dementia.  
Study IV estimated the impact of SW on change in cognitive performance before and after 
retirement. The study included 595 individuals at least 50 years of age at baseline who had 
been employed and who had undergone up to 9 assessments of cognitive performance over 
a period of 27 years. Latent growth curve modeling showed that SW and NW during mid-
life were not associated with greater rate of change in any of the cognitive domains (verbal, 
spatial, memory, and processing speed) later in life.  
In summary, the work in this thesis has combined unique population-based data sources 
and modern epidemiological methods to evaluate the role of sleep and SW in dementia and 
cognitive aging.  While SW did not appear to explain differences in rate of normative 
cognitive change in later life, findings indicate that SW and sleep characteristics are 
associated with increased risk of dementia.  
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1 INTRODUCTION 
As the aging population continues to grow, as does the impetus to understand what leads 
one to age well and another less so. In this thesis, particular interest surrounds why one’s 
cognition remains relatively intact and at the other end of the spectrum another’s takes a 
pathological turn. While genetic factors to some degree influence the variation in 
cognitive abilities1, 2 and dementia3 in later life, the balance that is explained by 
environmental factors remains partly unknown.  
Dementia is characterized by debilitating cognitive and functional decline and poses a 
major burden for the dementia-afflicted patient, family caregivers, healthcare 
professionals, and the society at large.4, 5 It was estimated in 2017 that close to 50 million 
people of all ages worldwide were living with dementia; this number is expected to jump 
to about 130 million in 2050.5 The economic toll related to dementia is also steep with a 
projected global cost of above 1 trillion US dollars.5  In light of these startling numbers, 
recent reports suggest that the age-specific prevalence (proportion of cases) as well as 
incidence (the rate of occurrence of new cases) of dementia is declining6-8, which may 
have been in part due to rising educational levels and lifestyle changes, among other 
factors. What we do know is that these changes have not been due to drug treatments for 
halting the progression and reversing the functional effects of dementia, as such 
treatments so far do not exist despite decades of research and billions of dollars devoted 
to drug discovery.9, 10 Overall, the changing trends of dementia incidence are encouraging, 
though it should be borne in mind that as long as the elderly population increases so will 
the absolute number of people with dementia. While dementia is highly prevalent in the 
elderly population, the majority experience cognitive decline without signs of pathology, 
also referred to as cognitive aging. Population aging means that it is also increasingly 
important to pinpoint factors that may accelerate cognitive aging. Although there is a 
huge research effort to determine factors associated with cognitive health in older age, 
only a small part of the variance in cognitive aging and dementia has been explained. 
A factor that has been explored in relation to risk of dementia (but shown inconsistent 
findings), and one that is potentially modifiable, is sleep. In 2015, results from a survey 
on brain health administered by the American Association of Retired Persons indicated 
that 84% of adults aged 50 and older were interested in learning more about sleep in 
relation to brain health.11 This is unsurprising given that this rejuvenating feature takes 
up approximately a third of our lives, and that the quantity and quality of sleep tends to 
decrease in older age12 and particularly for persons with dementia.13 Another third of our 
lives is spent at work (in working populations). An employment practice that in many 
cases directly impacts sleep is shift work (SW),14 in which a fifth of the global workforce 
is engaged.15  
 
This thesis comprises 4 studies that all utilize an epidemiological approach to understand 
how sleep and SW are associated with dementia and cognitive aging. 
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2 BACKGROUND 
2.1 A BRIEF INTRODUCTION TO EPIDEMIOLOGY 
Epidemiology is “the study of the distribution and determinants of disease frequency in 
human populations and the application of this study to control health problems.”16 
Classical applications of epidemiology focus on descriptive investigations while modern 
applications emphasize the search for causes and effects of health-related factors and 
outcomes, the latter of which has led to the development of models of causation and 
have been used in the work within this thesis.   
 Causal inference and DAGs 
When one thinks of causation in epidemiological research, the Bradford Hill Criteria 
and its nine aspects of association come to mind.17 Since the publication of these causal 
guidelines in 1965, which have been useful for its intended purpose, additional tools for 
causal inference have come into play. A handy tool used for establishing as well as 
visualizing directions of supposed relationships between an exposure, an outcome, and 
other related factors is the Directed Acyclic Graph (DAG) (Figure 2.1). 
To put this into context, let us apply the DAG to the analysis of the association between 
shift work (exposure) and dementia (outcome). An arrow indicates an association as 
well as the (assumed) direction of association between two variables. Whether the 
association is positive or negative, or to what extent the association is positive or 
negative (magnitude) is not shown in the DAG. A confounder, such as education in this 
example, is a factor that influences both the exposure and the outcome. To detect 
whether an association between the exposure and the outcome is influenced by a 
confounder, we need to condition on the confounding variable, i.e. by means of 
statistical adjustment, stratification, or sample restriction, which would close the path 
through the confounder. 
 
 
 
 
 
 
 
 
Figure 2.1. DAG illustrating directions of associations with a confounder (top) and mediator 
(bottom).  
Exposure Outcome 
Confounder 
Exposure Outcome 
 Mediator 
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A mediator, such as cardiovascular disease (CVD) in this example, lies in the causal 
pathway between the exposure and outcome. One may choose not to adjust for the 
mediator in order to identify the total effect of the exposure on the outcome. It is also 
possible to adjust for the mediator to estimate the direct effect of the exposure on the 
outcome. But one must be aware that adjusting for a mediator may, in the presence of 
unmeasured confounding between the mediator and the outcome, open up the path 
through that unmeasured confounder, which may lead to spurious associations. In the 
absence of mediator-outcome confounding, adjusting for a mediator would theoretically 
attenuate the association between the exposure and the outcome. 
A single factor may increase the risk of an outcome, but rarely does the causal mechanism 
leading to the outcome involve a single factor, but rather a multitude of factors. When the 
effect of the exposure on the outcome differs as a function of another factor (moderator 
or effect modifier), such an effect is referred to as interaction or effect modification. 
Overall, the development of a disease or outcome is an intricate and multifactorial 
process, and dementia and cognitive aging are not exceptions to the rule.  
 
2.2 DEMENTIA 
Dementia is a syndrome that encompasses a group of a chronic and debilitating diseases 
characterized by the progressive deterioration of cognitive processes such as memory, 
language, judgment, and behavior to the extent that normal activities of daily living are 
hindered.18 Depending on the dementia subtype, there are different pathogeneses of 
cerebral atrophy.  
The two major subtypes of dementia include Alzheimer’s disease (AD) and vascular 
dementia (VaD), in which AD represents approximately 70% of all cases while VaD 
accounts for 20 to 30%. Other causes of dementia include dementia with Lewy bodies 
(DLB) and frontotemporal dementia (FTD).19  
AD is a neurodegenerative disease and is characterized by two abnormal structures that 
are thought to develop independently of each other: extracellular amyloid plaques, also 
called senile plaques, which accumulate in the brain due to defective clearance of beta 
amyloid (Aβ) upon cleavage malfunction from the larger amyloid precursor protein; and, 
intracellular neurofibrillary tangles that are made up of tangles of hyperphosphorylated 
tau (p-tau) protein. Abundance of both aberrant structures in the brain leads to loss of 
connection between neurons, thereby diminishing cell function and giving rise to cell 
death.20 Interestingly, while plaques and tangles have been considered hallmarks of AD, 
some studies have indicated that not all persons diagnosed with AD showed plaques and 
tangles, and not all persons with AD pathology at death were cognitively impaired for 
their age when they were alive.21-23 AD may be further differentiated into early-onset 
(onset age between 30 to 60 years) and late-onset AD (onset age after 60 to 65 years). 
Early-onset AD represents about 4% of AD cases and is typically familial autosomal 
dominant, meaning that its occurrence is caused by inheriting a copy of a mutated gene. 
Up to 10% of early-onset AD cases are explained by mutations in any of the following 
three genes: amyloid precursor protein (APP), presenilin-1 (PSEN1), or presenilin-2 
 4 
(PSEN2).24 Late-onset AD on the other hand is to a large extent sporadic (no family 
history of AD).24  
The second most common form, VaD, also known as vascular cognitive impairment, is 
loss of cognitive functioning resulting from cerebrovascular disease such as stroke, which 
leads to the development of vascular brain lesions.25  
Fundamentally, where neuronal death stems from misfolding of proteins in the brain in 
AD, cell damage in VaD is caused by lack of oxygen due to disturbance in the blood supply 
to the brain.26 In practice, however, the delineation between subtypes is not quite as 
clear-cut. During a visit to the memory clinic, one physician, when asked about the 
prevalence of VaD, replied with some skepticism, “Is there really such a thing?” To him 
and others tasked with making a differential diagnosis, discerning isolated VaD from AD 
is a challenging endeavor as a diagnosis of VaD would require that there is an absence of 
degenerative pathology (which is difficult to ascertain pre-mortem). Then there is mixed 
dementia (also called multifactorial dementia) which is the coexistence of AD and VaD 
(as well as with other causes of dementia) wherein most dementias fall on a spectrum 
between AD and VaD.27, 28 A recent review reported that the prevalence of mixed 
dementia pathology could be up to 74%.27  
Due to the substantial overlap between different subtypes and the challenges in 
differential diagnosis, we focused on all-cause dementia in older age as the outcome of 
interest. In Study II where we estimated genetic influences for various phenotypes, all-
cause dementia as well as AD were examined.  
 
2.3 COGNITIVE AGING 
Older persons who are not diagnosed with dementia also experience normative cognitive 
aging, also called age-related cognitive decline, non-pathological aging, or simply 
cognitive aging.29, 30 This condition is defined as having a measurable decline in cognitive 
performance due to natural maturational processes in which cognitive factors such as 
verbal abilities, spatial abilities, memory, and processing speed are affected, but not to 
the extent wherein daily functional independence is compromised.29, 31  
 
The level and rate of decline of various cognitive domains vary between individuals, and 
by age, with certain domains being more age-sensitive than others.32 Verbal ability is the 
ability of using and understanding language. Performance in verbal abilities increases 
until midlife, is stable thereafter, and begins to slowly decline around the age of 70.33 
Performance in verbal ability may be assessed with tests involving synonyms and 
antonyms, analogies, and other tests for measuring one’s ability to understand verbal 
information.34 Spatial ability is the ability one can understand, judge, and remember the 
spatial relations among objects, and be able to visualize objects in the mind. An example 
would be reading a map and being able to navigate oneself. This cognitive factor starts to 
decline during middle age is assessed for example using figure logic, block design, and 
card rotations tests.35 Memory comprises different domains. Short-term memory (also 
called working memory) such as remembering a sequence of numbers in a short span of 
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time remains stable into very late life. Tests such as forward and backward digit span 
memory assess working memory. Long-term memory in itself can be divided into two 
subtypes. One is the unconscious preservation of memory of skills, sometimes referred 
to as implicit long-term memory, such as driving a car or playing the piano, which 
remains stable into late adulthood and declines slowly. The other is the conscious 
recollection of knowledge, which is also known as explicit long-term memory; this begins 
to worsen earlier in life but at a slow rate, and then at a faster rate later in old age.36 Tests 
involving picture memory, names and faces, and the Consortium to Establish a Registry 
for Alzheimer’s Disease (CERAD) word list were used in the studies in this thesis to assess 
long-term memory.35 Processing speed measures how fast one can process information 
and perform mental operations. The slowing of processing speed occurs earlier 
beginning at age 30.37, 38 This can be measured using symbol digit and figure identification 
tests.35, 38 While it is possible for different cognitive domains to be tapped by different 
tests, the domains are not isolated islands. For example, verbal ability relies on the ability 
to retrieve information from long-term memory, and processing speed predicts decline 
in other domains.38 A global score of cognitive ability can be derived from a combination 
of these cognitive domains.   
 
2.4 ETIOLOGY OF DEMENTIA AND COGNITIVE DECLINE 
Old age is the strongest risk factor for dementia. After the age of 65, the risk of AD doubles 
every 5 years.39 Senescence, while highly related to dementia, is not a causal factor as not 
everyone develops dementia; therefore, dementia is not a normal part of the aging 
process. Twin studies have demonstrated that the heritability for dementia and AD is 
estimated to be about 50% to 80%.40-42 The presence of the Ԑ4 allele of the apolipoprotein 
E (APOE) gene represents the strongest genetic risk factor for AD.43  
 
Besides old age and genetic susceptibility, research has shown that higher educational 
attainment is associated with higher cognitive ability44 and lower risk of dementia in old 
age.45, 46 This association may be explained by the cognitive reserve hypothesis, that is, 
individuals with higher levels of education may have enhanced neural compensatory 
ability, thereby mitigating the burden of brain pathology.45, 47 Socioeconomic status 
(SES), which is highly correlated with education, is another factor associated with 
dementia. Higher educational attainment has been shown to be a protective factor for 
dementia, and this may be due to lower-level occupations typically being associated with 
behaviors and lifestyles that are related to higher dementia risk.48  
 
Reports on the association between sex and dementia risk is mixed. Previous studies have 
shown that, among the very old, being female is a risk factor for AD, but not for VaD. This 
is perhaps explained by longer survival among women and earlier cardiovascular-related 
deaths among men leading to a survival bias.49 Well-researched lifestyle factors in midlife 
related to cognitive decline and dementia include physical activity, cigarette smoking, 
and alcohol consumption.39, 50 Medical conditions associated with both VaD and AD 
include depression, stroke and non-stroke CVD, and CVD risk factors such as 
hypertension, obesity, hyperlipidemia, type II diabetes and other metabolic disorders.50 
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2.5 SLEEP 
An important and potentially 
modifiable factor that may influence 
cognitive function and risk of dementia 
is sleep. Characteristics of interest 
include quantity and quality of sleep, 
chronotype (a person’s propensity to 
sleep at a particular time within a 24-
hour period), and disordered breathing. 
Sleep architecture for persons with 
cognitive impairment or diagnosed 
with dementia differs from cognitively 
intact individuals.  
 
A normal sleep cycle in adults lasts for 
approximately 90 minutes. Within each 
cycle, a person goes through four stages 
of sleep. The first three essentially 
dreamless stages of sleep (N1-N3) occur during non-rapid eye movement (NREM) sleep. 
The last stage of sleep during which dreams mainly occur is called rapid eye movement 
(REM) sleep.51, 52 Humans shift from very light sleep during N1 to basic sleep during N2, 
and then to very deep sleep during N3. N3 sleep is often referred to as slow wave sleep 
(SWS) due to the presence of delta amplitude waves seen during this stage in 
electroencephalography (EEG) recordings. It is during SWS when neuronal regeneration 
and cellular repair occurs. The last NREM stage begins to decrease after middle age and 
is reported to be nonexistent after age 90.12  
 
Normal aging is accompanied by physiologic changes in sleep53 and is associated with 
greater sleep latency (the length of time it takes to transition from wakefulness to sleep), 
sleep fragmentation, earlier awakening due to phase advance of the circadian clock, 
increases in stage N1 and N2 sleep,52 decreases in stage N3,54 and higher prevalence of 
daytime napping.53, 55  
 
Older individuals with cognitive impairment or diagnosed with dementia tend to 
experience similar age-related sleep changes such as greater difficulties falling asleep and 
restlessness during the night to the extent that sleep is disrupted. This then leads to 
noticeable sleepiness during the daytime,52 which is associated with a decreased 
likelihood of being able to perform activities of daily living.56 In addition to daytime 
sleepiness, some patients with dementia experience sundowning, which is the exhibition 
of behavioral problems such as confusion, restlessness and agitation that begins at dusk 
and lasts into the night.52  
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Atypical characteristics of sleep such as disturbances affecting sleep duration and quality 
in persons with cognitive impairment is perhaps due to impaired circadian rhythms. The 
circadian system is one of two body systems that regulates the sleep-wake cycle, the other 
system being sleep-wake homeostasis, wherein homeostatic sleep pressure increases 
with every waking hour, and decreases once asleep.57 Circadian rhythms oscillate with a 
period that is approximately 24 hours, hence the term ‘circadian’, which is derived from 
the Latin circa (“around”) and diem (“day”). They are mainly operated by an endogenous 
biological clock located in the suprachiasmatic nucleus within the hypothalamus, and are 
sensitive to so-called Zeitgebers (literally meaning “time giver” in German), which are 
exogenous stimuli such as light, temperature, noise, food availability, and social cues, to 
name a few.58 These Zeitgebers entrain the biological clock to the 24-hour light/dark 
cycle of the Earth. Interestingly, in the absence of entrainment from Zeitgebers, the 
endogenously generated circadian rhythms would continue on a period that is just over 
24 hours on average (though this would make for a rather dreary existence). With the 
help (or interference) of Zeitgebers, circadian rhythms can be entrained or reset. 
 
The resetting period involves desynchronization of endogenous circadian rhythms and 
exogenous factors, which is often seen in shift-workers and persons experiencing jet lag. 
It is hypothesized that disturbances in circadian rhythms may be involved in various 
disorders and disease processes, including type II diabetes, obesity, and CVD by directly 
mediating glucose and lipid metabolism.58 
 
Regarding the relationship between sleep and cognition, research has shown that 
reduction of sleep acutely59 or chronically 60 will lead to pronounced increases of 
sleepiness and impaired cognitive performance, including working memory 
performance. Disordered sleep has also been reported to be highly prevalent in persons 
with mild cognitive impairment and dementia.61-64 Much research has been done on 
investigating the adverse acute effects of interrupted and deprived sleep on cognitive 
performance that is measured hours or days later.65 While there have been studies 
examining the longer-term effects of sleep on late life cognition and dementia 
development, there has been greater focus on sleep-disordered breathing and sleep 
quantity and quality—with conflicting findings—and very little on chronotype.66, 67 
 
Studies examining sleep prior to or during the preclinical phase of dementia, which could 
extend beyond 20 years,68 while taking into account initial cognitive function are 
important for providing a better understanding of whether the sleep trait of interest is a 
risk factor or risk marker.    
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2.6 SHIFT WORK (SW) 
SW is a necessary employment practice that has emerged as a consequence of society’s 
demand for 24-hour service69 and has been around ever since the invention of the 
lightbulb in the 1800s, which allowed for work to continue or begin after the setting of 
the sun.70 Approximately one in five of the working population in high and middle-income 
countries are shift-workers,69 and about 30% of rotating and night shift-workers 
experience chronic insomnia and excessive sleepiness.71 In Sweden, 22.5% of the 
working population work shifts and 16% work night shifts.72 
 
In broad terms, according to the National Sleep Foundation, SW is “work that takes place 
on a schedule outside the traditional 9AM - 5PM day.”73 Work schedules that include 
shifts can include fixed night or evening shift schedules, rotational shift schedules, and 
on-call schedules.74 Such schedules are typically implemented in, for example, security 
industries, the healthcare sector, factory work, and jobs in construction, roadwork, and 
power plants. 
 
Rotational SW covers a variety of work schedules. A common rotational schedule used in 
Europe entails clockwise rotation from morning to afternoon to night shifts, with no more 
than three successive nights per block. For instance, this means working 7AM - 3PM for 
three shifts, 3PM - 11PM for three shifts, 11PM - 7AM for three shifts, and then 3 days off 
to recuperate from the sleep-wake cycle shifts.75 The reason for having short blocks is to 
avoid drastic resetting of the biological clock, though research has shown that there is 
loss of 1 to 4 hours of sleep per night during the 3-day recuperation period.76 A ‘fixed’ or 
‘permanent’ shift schedule is when a person (usually a crew of workers) works the same 
shift all the time. Historically, to not have shift changes at all was the circadian gold 
standard based on the idea that a fixed shift schedule imitated a typical day work 
schedule with fixed work hours during the day. In reality, however, very few working 
permanent shifts, particularly the night shift—evocatively known as the ‘graveyard 
shift’—can manage a complete circadian shift since most cannot opt out of family and 
social functions that fall during daytime hours. 76  
 
In this thesis, both a broad and narrow definition of SW is used. SW refers to any type of 
schedule that alternates between temporal positions, and this may include rotating SW, 
which contains night shifts. Night shift work or simply 'night work' (NW) refers to 
permanent night work or work that is part of a rotating schedule that includes night work. 
 
Working during irregular or unusual hours is known to affect sleep patterns and even 
cause sleep disorders.14, 77 SW, particularly if including night work (NW), is related to 
future increases in sleepiness78, and both night and morning shifts have been reported to 
reduce sleep by about 1.5 to 2 hours79, 80. Excessive sleepiness, shortened sleep time, and 
insomnia characterize a circadian rhythm disorder specific to shift-workers that is 
known as shift work sleep disorder.71 When sleep disturbances occur amongst shift-
workers, this may instigate insulin resistance, glucose intolerance, higher body mass 
index (BMI) and adverse neurocognitive consequences.58 Considering animal studies 
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that have shown circadian disruption to suppress hippocampal neurogenesis81, it is 
plausible for there to be deleterious cognitive effects due to chronic exposure to SW.  
 
So far, however, the effects of SW on cognition years later are less clear. A previous cross-
sectional study with a sample of 3,237 workers observed SW to be related to substantially 
lower cognitive performance.82 A more recent prospective study focusing on the male 
subset of the same French cohort noted similar findings.83 Men currently or previously 
exposed to any atypical work schedule scored lower on memory, speed, and global 
cognitive performance compared to men never exposed to any SW. Exposure to more 
than 10 years of rotating SW predicted lower global cognitive performance scores 
compared to those with no rotating SW experience.83 Another study by Devore and 
colleagues examined the effects of rotating night SW in midlife on mean cognition levels 
and rate of cognitive decline over a 6-year period, but no association was observed based 
on the study’s sample of 16,190 female participants from the Nurses’ Health Study.84    
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3 AIMS 
The overall objective of this work is to contribute to a better understanding of how 
sleep and SW influence incidence of dementia and cognitive aging in late life.  
 
Specific aims 
1. Study I: To study whether sleep characteristics predict risk of dementia while 
accounting for baseline cognitive functioning. 
 
2. Study II: To estimate the relative importance of genetic influences for late-life sleep 
characteristics, dementia and AD, and to examine whether dementia-related sleep 
characteristics modify the importance of genetic influences on dementia and AD. 
 
3. Study III: To investigate whether SW is associated with an increased risk of 
dementia. 
 
4. Study IV: To examine whether SW is associated with cognitive aging among 
persons not diagnosed with dementia.  
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4 DATA SOURCES AND MEASURES 
The saying is that Sweden is a gold mine for epidemiological research. This stems from 
the abundance of national population registers and the unique personal identification 
number (PIN) that is allocated to each of the 10 million inhabitants in Sweden. The PIN 
is a 10-digit number, with the first 6 digits representing one’s date of birth (YYMMDD) 
and the last 4 digits as a unique identifier that indicates the place of birth and sex of the 
individual (an even third digit indicates female; an odd number indicates male). The PIN 
is the basis of all Swedish public administration and it is this unique identifier that 
enables linkage of data from different register sources.85 By using register data with the 
help of the PIN, one can conduct a population-based cohort study with minimal risk of 
loss to follow-up, selection bias, and recall bias. 
 
In this chapter, registers and the register-based studies of aging used in this thesis are 
described.  
 
4.1 THE SWEDISH TWIN REGISTRY  
The Swedish Twin Registry (STR) is the largest and one of the oldest population-based 
registry of twins in the world and is a collection of different birth-year based cohorts.86 
In total, the registry includes 194,842 twins born between 1886 and 2008.87 A main 
reason for the establishment of the STR in the late 1950s was to investigate associations 
between environmental exposures such as smoking and chronic diseases such as lung 
cancer while controlling for familial effects.86 As one can imagine, a great deal of human 
effort and coordination went into establishing the STR, which was maintained at 
Karolinska Insitutet (KI). In the beginning, the STR contacted all parishes in Sweden 
about multiple births that occurred during 1886-1925; twins born during this time are 
referred to as the old STR cohort. Later in 1970, information on all twins born 1926-1967 
were gathered from the National Board of Health and Welfare (in Swedish: 
Socialstyrelsen).86 Twins born during 1926-1958 are referred to as the middle STR 
cohort. The studies in this thesis focus on the old and middle cohorts of the STR.  
 
Zygosity assignments 
Zygosity assignments were made by genotyping, by being opposite sex, or based on a 
question about intrapair similarities (“During childhood, were you and your twin partner 
as similar as two berries [equivalent to the English phrase, two peas in a pod] or not more 
alike than siblings in general?”).87 If both members of a pair responded that they were 
similar, then the pair was classified as MZ. Twins from the old and middle STR cohort 
with undetermined zygosity and who had participated in SALT (see below) were given 
the question: “How often do strangers have difficulty distinguishing between you and 
your twin partner when you were children?” Twins who had replied that they were mixed 
up by strangers were classified as MZ. 
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 STR studies of aging 
Since the inception of the STR, the registry has acted as a valuable resource for medical 
research, including aging research. For instance, a series of sub-studies of aging based on 
the old and/or middle STR cohorts have hatched forth, including cross-sectional studies 
such as the STR 1973 questionnaire study, SALT, HARMONY, and TwinGene, and 
longitudinal studies such as SATSA, OCTO-Twin, and Gender.86 These STR-based studies 
provide the basis for this thesis. An overview of these studies is illustrated in Figure 4.1. 
 STR-1973 
KI has administered questionnaires that include demographic, medical, and 
environmental exposure variables to specific age-based STR cohorts since the 1960s. 
Questionnaires in 1961, 1963, 1967, and 1970 were sent out to the old cohort. In 1973, a 
questionnaire, which asked about work-related exposures such as SW, was sent out to all 
like-sexed pairs in the middle cohort (N=36,536), of whom 36,429 responded.86 This 
cohort is referred to as the STR-1973 cohort, and is one of the cohorts that was followed 
up in Study III.  
 SALT and HARMONY 
SALT 
A more recent STR wave contacted individuals of same- and opposite-sex twin pairs via 
a telephone interview, called the Screening Across the Lifespan Twin study (SALT), in 
1998-2002 that targeted all twins born in 1958 or earlier.86, 88 Thus, STR-1973 twins who 
survived to 1998 are included in the SALT cohort. A total of 61,767 individuals were 
invited and 44,825 responded. The telephone interview followed a structured 
questionnaire that included questions about illnesses and health, prescription and 
nonprescription medication use, occupation, education and lifestyle factors. Certain 
items were only administered to participants 65 and older, such as items concerning 
sleep and memory. Permission to review medical records was also asked.  
HARMONY 
SALT twins who were alive and aged 65 and older at the time of the interview were 
administered a cognitive screening module called the TELE. This was the basis of the 
Study of Dementia in Swedish Twins study, commonly referred to as the HARMONY study 
(based on the Swedish words for “health” [Hälsa], “genes” [Arv], “environment” [Miljö], 
“and” [Och], and “new” [NY]). The aim of HARMONY was to ascertain cases of dementia 
in all twins who were 65 and over at the time.89 Details regarding clinical ascertainment 
of dementia in HARMONY are described later in Section 4.4.2. 
Data on sleep habits from SALT were used in Study I and Study II and as a covariate in a 
sensitivity analysis in Study III. Data on cognitive functioning from HARMONY was used 
in Study I. Dementia ascertainment data from HARMONY were used in Study I, Study II, 
and Study III. 
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 TwinGene 
TwinGene is a cross-sectional study of older twins born 1911-1958 who had participated 
in SALT and in which both members of the pair were alive at the time the study was 
conducted in 2004-2008.87 A total of 10,714 individuals were successfully genotyped 
using Illumina OmniExpress. Genotype imputation was performed based on the data 
from the 1000 Genomes Project.90 Thus, APOE genotype information was available from 
TwinGene, which was used in a subsample analysis in Study III.  
 SATSA 
The Swedish Adoption/Twin Study of Aging (SATSA) is a longitudinal study of aging, with 
the base population made up of twins from the old and middle STR cohort who were 
separated before the age of 11 and reared apart, and a matched control sample of twins 
reared together based on sex, date of birth, and county of birth.91, 92 The main reason for 
the separation of twins was illness or death of parents or economic hardship.  
Data collection for SATSA began in 1984 with a questionnaire (Q1) and ended in 2014. 
Of the 2,845 individuals from the base sample who were mailed the Q1 questionnaire in 
1984, 2,019 individuals responded.35 In addition to the questionnaire component, SATSA 
included an in-person-testing (IPT) component. Altogether there was a total of 9 
questionnaire waves and 10 IPT waves. The mean baseline age in 1984 was 60.3 (SD 
14.0).   
The questionnaire included questions concerning health, sociodemographic factors, 
lifestyle factors, and work environment exposure such as SW. Questionnaires were 
mailed out in 1984, 1987, 1990, 1993, 2004, 2007, 2010, 2012, and 2014. 
The IPT involved an extensive cognitive battery, health examinations, and collection of 
biological samples. IPT assessments were conducted in 1986-88, 1989-91, 1992-94, 
1995-98, 1999-2000, 2002-04, 2005-07, 2008-10, 2010-12, and 2012-14, and were 
administered at primary care centers or offsite in the participant’s place of residence, 
wherever convenient. Data collection was done by trained registered nurses. To be 
considered for IPT participation, both members of a pair had to have responded to Q1, 
and they had to be at least 50 years of age. A total of 645 individuals participated at the 
first IPT occasion (IPT1). Thereafter, those who had participated in IPT1, or those who 
had turned 50 during the study period, were invited to take part in subsequent IPTs up 
to IPT5. For IPT4, a subset of IPT participants (n=40) were interviewed due to funding 
considerations. There were 859 individuals who had participated in at least one IPT. 
SATSA has a good response rate with more than 90% of participants having returned for 
each IPT wave with the exception of IPT4, and not counting those who had died during 
the course of the study. Over 76% of the sample has participated in at least three IPT 
waves. 
Data and documentation for the first 6 questionnaire waves and 7 IPT waves of SATSA 
are publicly available at the National Archive of Computerized Data on Aging (URL: 
https://www.icpsr.umich.edu/icpsrweb/DSDR/studies/3843).93  
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In Study IV, information on SW (available at Q1) and cognitive performance (measured 
in IPT1-9) were used, Clinical diagnoses of dementia were made in SATSA, and these data 
supplemented register data on dementia and AD in Study II.  
 OCTO-Twin 
The Origins of Variance in the Old-Old: Octogenarian Twins (OCTO-Twin) study 
concerned individual differences among older aged adults.94 OCTO-Twin is similar in 
design to SATSA and includes questionnaires and IPTs, including cognitive assessments. 
The base population was like-sexed twin pairs drawn from the old cohort of the STR. A 
total of 702 individuals (351 complete pairs) participated at baseline. The mean baseline 
age was 83.6 years (SD 3.2). Participants in OCTO-Twin were invited to take part in 5 
IPTs at rolling 2-year intervals. Clinical diagnoses of dementia were done in this OCTO-
Twin subset; these data supplemented register data on dementia and AD in Study II.   
 GENDER 
Aging in Women and Men: A Longitudinal Study of Gender Differences in Health Behavior 
and Health among Elderly, more often referred to as the GENDER study, followed 
opposite-sexed twin pairs born 1906-1925 drawn from the old cohort of the STR.95 The 
objective of Gender was to investigate differences in gender in various measures of health 
and cognitive function. Of the 1,843 individuals who responded to the baseline 
questionnaire, a subsample of 498 individuals (249 twin pairs) aged 70-79 years 
participated in GENDER’s first IPT beginning in 1995. Altogether there were 3 waves of 
IPTs that were administered on a 4-year rolling schedule between 1995 and 2005. The 
IPT component in Gender included cognitive assessments and were much like that in 
SATSA and OCTO-Twin.96 Dementia was ascertained clinically in GENDER, and these 
information were used towards the construction of the dementia and AD variables in 
Study II.  
Generally, SATSA, OCTO-Twin, and GENDER were consistent in terms of information 
collected.  
4.2 THE SWEDISH MILITARY SERVICE CONSCRIPTION REGISTER 
Until 2007, military conscription was compulsory for all Swedish men. Around the age of 
18-20, all men participated in conscription tests that included assessments of exercise 
and lung capacity, BMI, mental health, and cognitive ability.97 Exam results have been 
documented electronically since 1969. Regarding the cognitive component, verbal ability, 
spatial ability, logic inductive and technical ability were evaluated. Raw scores from these 
four tests were standardized into z scores. A general cognitive ability score was generated 
by summing the scores together, resulting in a total score ranging 1 to 40 points, with a 
higher score demonstrating stronger cognitive performance.101 
 
In Study IV, a sensitivity analysis was performed on a subset of men born in 1936-1948 
who had participated in SATSA and undergone military conscription and thus had data 
on early adult cognitive ability.  
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Figure 4.1. Overview of studies of the Swedish Twin Registry that provide the basis of this thesis. Modified from Karlsson 2017.98 
Study I includes data from SALT/HARMONY.  
Study II includes data from SALT/HARMONY, SATSA, OCTO-Twin, and GENDER.  
Study III includes data from SALT/HARMONY, STR-1973, and TwinGene. 
Study IV includes data from SATSA and SALT.
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4.3 NATIONAL HEALTHCARE REGISTERS 
With the PIN, the STR and its sub-studies can also be linked to a number of population 
health registers, namely the National Patient Register, the Prescribed Drug Register, and 
the Causes of Death Register, from which data used in this work are extracted from.  
 National Patient Register 
Follow-up of the health of the Swedish population has been maintained by the National 
Board of Health and Welfare since 1964, which was when the National Patient Register 
(NPR) was established.99 For everyone living in Sweden, the NPR collects information on 
hospitalization for diseases coded as the International Classification of Diseases (ICD) 
codes relevant at the time, as well information on dates of admission and discharge. In 
the NPR, inpatient care, i.e. overnight hospitalizations, was recorded since the beginning 
in 1964, psychiatric care recorded since 1973, and outpatient visits from hospital-based 
or specialist clinics since 2001. Primary care is not recorded in the NPR.100 There was 
incomplete geographical coverage of patient care in the 1960s, with only 6-12 counties 
in Sweden included in the NPR (Sweden is divided into 21 counties).101 By 1987 and 
onwards, coverage of care was nationwide.  
 Prescribed Drug Register 
The Swedish Prescribed Drug Register (PDR) is a relatively newer register that was 
initiated on July 1, 2005.102 The PDR contains information on all prescribed 
pharmaceuticals dispensed to all Swedish residents. The National Corporation of 
Swedish Pharmacies, a company owned by the Swedish state, is responsible for the data 
collection for the PDR. The data are then transferred to the National Board of Health and 
Welfare each month. For each observation, the register includes, but is not limited to, the 
date the drug was dispensed, the substance and brand name of the dispensed item, and 
the dispensed amount and expenditure.102 The PDR does not include data on over the 
counter medications. All drugs follow the Anatomical Therapeutic Chemical (ATC) 
classification system. For the purposes of the work in this thesis, the PDR serves as an 
additional source of data on dementia as well as on use of hypnotics and sedatives. 
 Causes of Death Register 
The Causes of Death Register holds information on deaths for all residents of Sweden, 
regardless of whether the death was in Sweden or abroad.103, 104 Stillborn deaths and 
individuals who died in Sweden but do not hold a permanent residency are not registered 
in the CDR. The National Board of Health and Welfare has been responsible for 
maintaining the CDR since 1952, which has established nationwide coverage since 1961. 
Information such as age and date of death, the underlying cause of death, and the 
contributing cause(s) of death are entered into the CDR. New deaths are registered on a 
continual basis.  
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4.4 DEMENTIA ASCERTAINMENT 
Data on incident dementia (after study baseline) came mainly from the national health 
registers described above, and were used to construct the dementia variables in Study I, 
Study II, and Study III.  Register-based dementia diagnoses were supplemented with 
additional clinical diagnoses made in the STR sub-studies of aging in Study II (conducted 
last, chronologically). 
 Ascertainment of dementia from registers (Study I, Study II, Study III) 
Incident cases of dementia were ascertained via record linkage between the STR with the 
NPR, PDR, and CDR. At the time the four studies of this thesis were performed, NPR data 
were available for 1967-2014, PDR data were available for 2005-2014, and CDR data 
were available for 1952-2014. Note that since this thesis concerns incident cases of 
dementia (Study I, Study II, Study III), and that the earliest study baseline was in 1973 
(Study III), only register-based dementia data starting from 1973 were extracted. 
Therefore, ICD-8 (1969-1986), ICD-9 (1987-1996), and ICD-10 (1997-current) codes 
were used to identify cases of all-cause dementia and specific dementia subtypes (Table 
4.4.1a).  
From the NPR, data on hospital admission date (inpatient) or date of dementia diagnosis 
(outpatient) was used to construct the variable for date/age of dementia onset. Both 
primary and additional diagnoses were used. From the PDR, the date the dementia 
medication (class N06D) was dispensed was considered as the date of AD onset, since the 
anti-dementia drugs prescribed in Sweden are specific for managing mild to severe AD.105 
The full list of the medications used to derive the AD variable is shown in Table 4.4.1b. 
From the CDR, data on the date of death with dementia as the primary or contributing 
cause of death was extracted. If there was information on dementia dates from multiple 
register sources, the earliest date was used for the date of dementia onset variable.  
Dementia diagnoses from the NPR and CDR have been validated against clinical 
diagnoses identified from six Swedish population-based studies.106 For all-cause 
dementia diagnoses in the NPR and CDR combined, the sensitivity—which is how well 
the registers can detect dementia cases and is calculated as the number of cases 
ascertained in the registers divided by the number of cases identified in the population-
based studies—was 63%. The specificity—which is how well the registers can detect 
non-dementia cases and was calculated as the number of non-cases ascertained in the 
registers divided by the amount of non-cases identified in the population-based studies—
was 99.8%.106 The work within this thesis was mainly concerned with all-cause dementia.  
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Table 4.4.1a. ICD codes for identification of dementia. Modified from Karlsson 2017.98 
                       ICD 
 
Dementia 
ICD-8 
1969-1986 
ICD-9 
1987-1996 
ICD-10 
1997-current 
Alzheimer’s disease 290 290A/B F00 
 331A G30 
Vascular dementia 293.0, 293.1 290E F01 
Other dementia  290X/W F02-03 
 294B G311 
 331B/C/X G318A 
  F051 
 
Table 4.4.1b. ATC codes for anti-dementia drugs in Sweden.  
 
 
 
 
 Clinical ascertainment of dementia from STR sub-studies (Study II) 
For the clinical ascertainment of dementia in the four STR studies (HARMONY, SATSA, 
OCTO-Twin, and GENDER), the general procedure is to: 1) administer a cognitive 
screening, and 2) perform a clinical evaluation for those who screened positive for 
dementia or conduct a consensus conference, in which a group of specialists review all 
relevant study protocols and medical records to come to a differential diagnosis. 
 Cognitive screening 
In SATSA, OCTO-Twin, and Gender, the MMSE as well as other cognitive tests including 
tests of spatial ability, processing speed, verbal ability, and memory were used for 
neuropsychological assessment of cognitive function.35, 94, 95 In HARMONY, the TELE was 
used as a telephone cognitive screening tool.89 As part of the TELE, participants were 
given a 10-item mental status questionnaire (MSQ), asked to recall three words, were 
presented three pairs of words and were asked to explain why they were similar, and 
questioned about health and daily functioning. In the event that the twin performed 
poorly on the TELE, an informant supplied information about the twin with the BRDS, 
which assessed to what extent the twin’s cognitive status interfered with everyday 
functioning. An ordinal cognitive scale ranging from intact cognition (0) to cognitive 
dysfunction (3) was created based on information from the TELE and BDRS.89 A 
description of the ordinal cognitive scale can be found in Table 4.4.2. HARMONY 
participants who received a score of 3 indicating cognitive dysfunction were referred to a 
full clinical work-up.  
 
 
ATC code Group name Drug name in Sweden 
N06D Acetylcholinesterase (AChE) 
inhibitors  
(for mild to moderate AD) 
 Donepezil 
 Galantamine 
 Rivastigmine 
NMDA receptor antagonist 
memantine  
(for moderate to severe AD) 
 Memantine 
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Table 4.4.2. Ordinal cognitive scale in HARMONY based on the TELE and informant interviews.89  
Cognitively intact 
(0) 
Minor errors   
(1) 
Poor performance  
(2) 
Cognitive Dysfunction 
(3) 
Completed TELE 
interview with no 
impairment in any 
domain. 
Completed TELE 
interview but with 
impairment in one 
domain (MSQ, 
similarities, or three-
word recall). 
Presence of errors in 
more than one domain of 
the TELE or the twin was 
unable to be interviewed 
but informant did not 
indicate that the twin had 
functional impairment. 
Presence of more than two 
errors on the MSQ items, a 
BDRS score of at least 1.5 
based on the informant 
interview, or the twin 
reported having functional 
impairment. 
 
Clinical work-up and diagnosis 
In HARMONY and up to the fourth wave of SATSA, twins who screened positive for 
dementia were referred to a full clinical work-up which generally followed the CERAD 
protocol.107 The work-up involved a team that included a nurse and a physician who 
performed a physical and neurological assessment, administered a neuropsychological 
battery, reviewed medical records, looked at onset and progression of memory or 
cognitive symptoms, collected blood for lab analysis, and referred some individuals for 
neuroimaging.89 Additionally in HARMONY, informants of the twin answered a Clinical 
Dementia Rating scale108 as well as a Neuropsychiatric Inventory concerning behavioral 
symptoms.109 In OCTO-Twin and Gender, and from the fifth IPT occasion in SATSA, 
ascertainment of dementia was based on psychological and physical health evaluations, 
decline in cognitive performance between waves, nurse’s impressions, and review of 
medical records including medical history and prescribed and non-prescribed drug use. 
Across the four STR studies, a dementia diagnosis was set during a multidisciplinary 
consensus conference according to DSM-III-R or DSM-IV criteria. A differential diagnosis 
was made based on NINCDS/ADRDA criteria for AD,110 and based on NINDS-AIREN 
criteria for VaD.25  
4.5 COGNITIVE MEASURES IN SATSA (STUDY IV) 
In SATSA, five cognitive composite factors – verbal abilities, memory, spatial abilities, 
processing, speed, and a general cognitive factor – were generated based on tests in a 
cognitive battery.  
Table 4.6 lists the specific tests, which had reliabilities ranging between .82 to .96,1  that 
were related to each cognitive factor as revealed by principal component analysis. Each 
test in the principal component analysis was standardized to the mean and standard 
deviation of IPT1 test scores. For ease of interpretation, the cognitive factor scores were 
transformed into T scores that had a mean of 50 and a standard deviation of 10. The 
individual cognitive tests were available at all IPT waves, and it was therefore possible to 
model trajectories of performance over time for each of these cognitive factors, which 
was done in Study IV.  
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Table 4.6. Five cognitive factors in SATSA (used in Study IV). 
 
 Verbal Spatial  Memory Processing 
speed 
General 
cognitive 
ability 
 
Cognitive 
tests 
-Information 
-Synonyms 
-Analogies 
-Block design 
-Card rotations  
(2-minute version) 
-Picture memory 
-Digit span 
forward & 
backward 
-Symbol digit 
-Figure 
identification 
-All tests 
 
 
 
4.6 EXPOSURE VARIABLES 
 Sleep characteristics (Study I and Study II) 
All information on sleep habits was self-reported and came from the Karolinska Sleep 
Questionnaire (KSQ), which was included in the SALT interview.  
Six sleep measures were used mainly in Study I and Study II, and as a covariate in Study 
III. Table 4.7 lists the six sleep measures as well as the specific KSQ sleep items that were 
used to construct the sleep measures.  
By design, five items (rise time, bedtime, disturbed sleep, difficulty falling asleep, and 
waking up too early in the morning) were administered to all SALT participants 65 and 
over. The other sleep items (repeated nighttime awakenings, not feeling rested upon 
awakening, difficulties awakening, and heavy snoring) were administered to a smaller 
subset of this 65+ year sample, identified randomly, due to funding considerations. 
Rise time (rising 8AM or later vs. earlier rising) and bedtime (going to bed 11PM or later 
vs. earlier bedtime) were dichotomized measures, with the 75th percentile rise time or 
bedtime value in the Study I population determining the cut-off point. This was done in 
order to detect delayed sleep phase rhythms. In Study I, sensitivity analyses on the 
association between rise time and bedtime with incident dementia was performed based 
on rise time and bedtime variables dichotomized at 70th, 75th, and 80th percentile cut 
points; similar findings were yielded compared to that from main analyses, indicating 
that the effects of late rise time and bedtime were not spurious.  
A time in bed (TIB) variable was calculated based on rise time and bedtime information. 
TIB was grouped as ≤ 6 hours (short), between 6 and 9 hours (reference), and >9 hours 
(long) based on the distribution of the study population in Study I and a meta-analysis 
that developed age-specific normative sleep values.12 This measure is similar to sleep 
duration. A notable difference is that TIB length is typically longer on average than the 
length of sleep duration because TIB includes the sleep latency period as well as the time 
awake when night-time awakenings occur. 
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To capture different dimensions of poor sleep, two validated sleep indices were used: the 
Sleep Quality Index and the Non-Restorative Sleep Index.111 The Sleep Quality Index is 
based on four KSQ items (see Table 4.7) and is used for capturing nocturnal symptoms of 
insomnia; these items were determined according to DSM-IV criteria of insomnia.111 The 
Non-Restorative Sleep Index is based on two KSQ items (Table 4.7) and is for capturing 
the extent to which sleep is refreshing.  
Heavy snoring was used as a marker of sleep-disordered breathing. A caveat with this 
measure is that one may not be aware of one’s snoring status unless living with others. 
 
Table 4.7. Sleep variables used in Study I and II.  
Items about sleep habits from the 
Karolinska Sleep Questionnaire (KSQ) 
Sleep variables based on 
KSQ items on the left 
During the last 6 months… 
 
What time do you usually get up? 
      Get up at [time] ____________ 
 
What time do you usually go to bed? 
      Go to bed [time] ____________ 
 
Time in bed (TIB) 
Short = < 6 hours 
Middle = ≥6 to 9 hours 
Long = ≥ 9 hours 
Rise time 
Rising time < 8AM 
Rising time ≥ 8AM  
Bedtime  
Bedtime < 11PM 
Bedtime ≥ 11PM  
How often, during the last 6 months, have you been affected by this 
problem? 
 
…Waking up too early and not being able to sleep again. 
   Never (0)   Seldom (1)   Sometimes (2)   Usually (3)   Always (4)    
 
…Feeling of not having had enough sleep upon awakening. 
   Never (0)   Seldom (1)   Sometimes (2)   Usually (3)   Always (4)    
 
…Experience disturbed or uneasy sleep. 
   Never (0)   Seldom (1)   Sometimes (2)   Usually (3)   Always (4)    
 
…Repeatedly waking up during the night and having difficulties 
falling back asleep. 
   Never (0)   Seldom (1)   Sometimes (2)   Usually (3)   Always (4)    
 
 
Sleep Quality Index  
(Range 0 to 4; Higher score = 
poorer sleep quality) 
How often, during the last 6 months, have you been affected by this 
problem? 
 
…Having trouble waking up in the morning.  
   Never (0)   Seldom (1)   Sometimes (2)   Usually (3)   Always (4)    
 
…Do not feel restored/rested upon awakening. 
   Never (0)   Seldom (1)   Sometimes (2)   Usually (3)   Always (4)    
 
 
Non-Restorative Sleep Index  
(Range 0-4; Higher score =  
less restorative sleep) 
How often, during the last 6 months, have you been affected by this 
problem? 
 
…Experience heavy snoring.  
   Never (0)   Seldom (1)   Sometimes (2)   Usually (3)   Always (4)    
 
 
Heavy snoring  
No 
Yes 
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 Shift work and night work (Study III and Study IV) 
SATSA – SW of all types (Study IV) 
In SATSA, at Q1 baseline in 1984, participants were asked if they worked shifts for the 
greater part of their life. Those who indicated that they had worked shifts were also able 
to give an open-ended response regarding the number of years that they had worked 
shifts. Participants were also asked if they had worked shifts in the last 12 months, i.e. 
their current shift work status. A general SW status variable (ever/never) and a SW 
experience variable with 4 categories (0 years; 1-9 years; 10-19 years; 20 or more years) 
were created. The SW variable from SATSA was the main exposure variable in Study IV.  
SALT – Night work (Study I, Study III and Study IV) 
The NW measure from the SALT questionnaire in 1998-2002 was based on the open-
ended item, “During about how many years have you had working hours that meant that 
you at least sometimes worked at night?” NW was grouped as ever/never and 
categorized into 4 levels (0 years; 1-9 years; 10-19 years; 20 or more years). NW was one 
of the main exposure variables in the main analysis in Study III, used in a subsample 
analysis in Study IV, and included as a covariate in a preliminary model in Study I.  
STR-1973 – SW of all types (Study III) 
In the STR questionnaire in 1973, the middle STR cohort was asked, “Do you work or have 
you worked shifts?” One was able to respond No or Yes, and specify for how long time in 
years one had worked shifts. This variable was treated as an ever/never variable as well 
as a categorical variable (0 years; 1-9 years; 10-19 years; 20 or more years). The SW 
variable from the 1973 STR questionnaire was one of the main exposure variables in 
Study III.  
Overlap of participants in SATSA, SALT and STR-1973 
The overlap of participants in SATSA and SALT made it possible to check if participants 
who had responded that they worked nights in SALT, had also responded that they had 
worked any-type SW in SATSA (Study IV). Of the SATSA individuals who had responded 
that they worked nights in SALT (n=47), 100% of these individuals had responded that 
they worked shifts in SATSA.  
There was also an overlap of participants in STR-1973 and SALT. One of the main 
limitations with the SW measures is that SW is measured at only one occasion in each 
study. This means that SW exposure is assumed to be fixed when in reality this may not 
have been the case. With the overlap of participants between studies and with two study 
sources of SW data, we were able to draw some scenarios concerning the length of 
exposure time (in years) to SW, or allow for SW exposure status to vary over time, which 
were done in Study III. 
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4.7 OTHER VARIABLES  
Age and sex were included as covariates in all final statistical models in the 4 studies in 
this thesis.  
Highest educational attainment was included as a covariate in all final models in Study I, 
Study III, and Study IV. While it is compulsory to attend school for years 1-9 today in 
Sweden,112  for the study population made up of individuals born between 1886 and 
1958, compulsory ‘basic’ or ‘elementary’ school (“folkskola” in Swedish) was 6 or 7 years 
of education.113 Thus, education was treated as a binary variable based on the 
distribution of educational attainment levels and earlier work on risk of cognitive decline 
and dementia in this older-aged cohort113 and was coded as ‘≤7 years educations / >7 
years education’ in Study I and Study III, and equivalently as ‘elementary 
education/higher education’ in Study IV.  
Covariates for behavioral, lifestyle, and work environment factors were based on baseline 
questionnaire data (SATSA, SALT, or STR-1973, whichever relevant) and included: 
smoking (ever/never), habitual alcohol consumption (consumed alcohol during the last 
month vs. no alcohol consumption during the last month), physical exercise (hardly any 
exercise, light exercise, moderate exercise, intense exercise), and BMI (kg/m2) with 
categories:: underweight (<18.5 kg/m2), normal weight (18.5–24.9 kg/m2), overweight 
(25.0–29.9 kg/m2), and obese (≥30 kg/m2).  
Manual work status was grouped as manual and non-manual work based on self-
reported occupation. A scale for complexity of work was created based upon the self-
reported occupation that the individual had for the greater part of his/her working life. 
Occupations were coded according to categories of the 1980 Swedish Population and 
Housing Census, which was then matched based on occupational descriptions to the 1970 
U.S. Census occupational classification system for which a score matrix was available and 
used to derive scores for work complexity ranging between 0 and 10.114 Higher scores 
reflected greater work complexity. 
Covariates for medical conditions and medication use were generally derived from 
baseline questionnaire data and included:  
 CVD, defined as ever having had angina pectoris, heart failure, high cholesterol, 
claudication or intermittent claudication, thrombosis, ischemic or hemorrhagic 
stroke, transient ischemic attack, cardiac, valvular murmurs or narrowing of the 
carotid arteries, and irregular heartbeat (yes/no). 
 Stroke, ischemic or hemorrhagic (ever/never). 
 Diabetes, Type I or II (yes/no). 
 History of cancer (yes/no). 
 Chronic obstructive pulmonary disease (yes/no) which was constructed based on 
whether one coughed with or without phlegm, or had bronchitis or emphysema. 
 Depression scale based on the 11-item short form of CES-D. 
 Hypnotics and sedatives use, including sleep medications (ever/never). 
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For CVD, stroke, diabetes, and use of hypnotics and sedatives, these questionnaire-based 
data were supplemented with register data. 
 Non-stroke CVD based on ICD codes from the NPR: 420, 450, 453.33(ICD-7); 410-
414, 440, 443.90 (ICD-8); 410-414, 440, 443X (ICD-9); 984, 3068, 3080, 3127, 
3141, 3158, FNC, FND, FNE, FNG00, FNG02, FNG05 (ICD-10). 
 Stroke based on ICD codes from the NPR: 330, 331.00, 331.01, 331.09, 331.99, 
332.00, 332.00-19, 332.29, 334.00-98 (ICD-7); 430, 431, 433, 434, 436 (ICD-8); 
430, 431, 434, 436 (ICD-9); I60, I61, I63, I64 (ICD-10). 
 Diabetes based on ICD codes from the NPR: 260.09, 260.20, 260.21, 260.29, 
260.30, 260.40, 260.49, 260.99 (ICD-7); 250.00-09 (ICD-8); 250A-H, 250X (ICD-
9), E10, E11, E12, E13, E14 (ICD-10). 
 Hypnotics and sedatives use based on the ATC code of N05C from the PDR. 
APOE genotype data came from TwinGene, and APOE status was categorized as APOE 4 
carrier versus APOE non-4 carrier.  
 
 
  25 
5 METHODS 
5.1 STATISTICAL METHODS 
 Cox proportional-hazards regression (Study I, Study II, Study III) 
The Cox model is a type of survival model well-known for its application to time-to-event 
data.115 Briefly, the Cox model is a semi-parametric model which allows for the 
distribution of the underlying baseline hazard to be unspecified or not directly estimated. 
The formula for the Cox proportional-hazards model is as follows: 
h(t;xi) = h0(t) exp(β’xi) 
where t is time, h0(t) is the baseline hazard function, x represents covariates and β 
represents their estimated coefficients. The effect estimate is the hazard rate or simply 
the hazard, which refers to the probability that an individual has an event at time t. A 
hazard ratio (HR), then, is the hazard in the exposed divided by the hazard in the 
unexposed. 
The model is based on the proportional-hazards assumption, which stipulates that the 
relative hazards is constant between exposed and unexposed groups over time. However, 
the magnitude of the hazards may vary over time, i.e. if the hazards in the exposed group 
increases over time, then the hazards in the unexposed group also increases 
proportionally along with it. The assumption can be tested using Schoenfeld residual 
tests and visually inspected via log-log survival plots. In all studies that employed Cox 
models, no statistically significant violations of the proportional-hazards assumption 
were observed.  
Additionally, to deal with the heteroscedasticity of data arising from relatedness 
(dependence) between members of a twinship, we included cluster-robust standard 
errors.   
 
 Twin methodology – Co-twin control design (Study I and Study III) 
In twin methodology, rather than treating the relatedness between members of a twin 
pair as a nuisance, here we take advantage of their unique relationship.  
The co-twin control method is an elegant research design for detecting the extent to 
which an association between an environmental risk factor and an outcome variable is 
due to familial confounding (shared early environmental or genetic factors influencing 
both the risk factor and outcome). If the association between a risk factor and an outcome 
attenuates or disappears in within-pair analyses, this would indicate presence of familial 
confounding. If the association further attenuates in within-pair analyses fitted to a 
subset of MZ twins (who share the same genome), this would provide additional support 
of genetic confounding, thereby providing a clearer picture of the extent to which causal 
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inferences can be drawn. A caveat, however, is that the method requires an adequate 
number of complete twin pairs, especially if the effect size of the risk factor is small. 
The co-twin control design can be applied to different types of regression models, 
including survival models. This is done by conditioning the model on pair membership. 
In a survival model setting as in Study I and Study III, twin pairs discordant for the 
outcome could mean that a) one twin developed dementia and the co-twin did not 
develop dementia during the study period, or b) both twins developed dementia, with 
one twin having developed dementia at an earlier or later age than the co-twin during the 
study period.  
 
 Twin methodology – Quantitative genetic design (Study II) 
Quantitative genetic designs further utilize the similarity, or the correlation statistically 
speaking, between members of twin pairs to quantify contributions of genetic and 
environmental factors to a trait. Quantitative genetic analyses are often performed within 
a structural equation modeling (SEM) framework to model variance and covariance 
matrices, which are then decomposed into latent (unmeasured) genetic and 
environmental components.  
 
Twin modelling: Univariate twin model 
In a classical univariate twin model for estimating heritability (the proportion of variance 
due to genetic variance), variance decomposition relies on the assumption that MZ twins 
share 100% of their genes, DZ twins share on average 50% of their segregating genes, 
that twin pairs share 100% of shared (or in common) familial environment, and that 
genetic and environmental components are independent. Thus, within-pair genetic 
correlations are assumed to be 1 for MZ twins and 0.5 for DZ twins, and that the shared 
environmental correlation is 1 for both types of twins. 
A phenotype is assumed to be influenced by genetic and environmental effects. 
Specifically, the total phenotypic variance within the population may be decomposed into 
the following biometric components: additive genetic effects (A), non-additive 
(dominance) genetic effects (D), shared or ‘common’ environmental effects (C), and non-
shared or ‘unique’ environmental effects (E). Shared environment is any environmental 
effect that makes twins in a pair similar to each other in terms of the phenotype such as 
parents, childhood SES, neighborhood, and so on. Non-shared environment is everything 
else and contributes to differences among family members, such as differential parenting, 
peers, school teachers, et cetera. Measurement error, assumed to be random, also goes 
into the non-shared environment term which is by definition uncorrelated between 
members within a pair. While four sources of variance are quantifiable, only three 
variance components may be estimated simultaneously using twin modelling. In Study II, 
we elected not to consider component D because the investigated traits indicated no 
evidence of dominant genetic influences (phenotypic correlations in MZ pairs were not 
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more than twice that of DZ pairs). Further, the component of A is a good approximation 
of genetic effects (A+D). Resulting from this is an ACE model.  
 
In quantitative genetic model fitting, the first step is to fit a saturated model in which 
there are no constraints on mean, variance, and covariance structures, i.e. means and 
variances for MZ and DZ twins as well as for each twin within a pair are estimated. By 
building a saturated model, we may test whether means and variances are equal by twin 
order and by zygosity using the likelihood ratio test (LRT). Next, genetic twin models 
such as the ACE model, which is a sub-model or ‘nested’ model of the saturated model, 
may be compared to the saturated model using LRT. The ACE model can then be 
compared to an even more parsimonious model such as the AE model. These model 
fitting steps were undertaken in Study II, where estimates were mainly based on AE 
models since we noted that the additional parameter of C generally did not improve the 
model fit.   
 
The total phenotypic variance is the sum of genetic and environmental variance 
components. These components are proportions of variance in a phenotype and thus 
reflect the relative importance of the component. For binary traits, the components sum 
up to 1. Taking the AE model as an example: 
 
 
 
By definition, heritability (h2) is then the proportion of variance (the similarities or 
differences) in a trait that is attributed to genes. It is not the proportion of a trait 
attributed to genes.  
 
 
Twin modelling: Moderation model  
The univariate twin model can also be extended to include a moderator, which results in 
what we call a univariate moderation twin model, or simply a moderation model. A 
moderation model addresses whether Trait A (i.e. sleep) moderates genetic and 
environmental variance components underlying Trait B (i.e. dementia). Figure 5.1.3 
illustrates a path diagram of the ACE twin moderation model used in Study II.  
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Figure 5.1.3. Univariate ACE moderation twin model estimating the sleep-moderator effect on 
genetic and environmental influences on dementia/AD.  
Note: A = additive genetic influences; C = common environmental influences; E = unique environmental 
influences; rMZ = correlation in MZ twins; rDZ = correlation in DZ twins. Means and variances were 
specified separately. In the means model, for each twin, linear and quadratic age, sex, and the moderator 
(M1) of twin 1 and the moderator (M2) of the co-twin was controlled for. For the variances, genetic, shared 
and non-shared components of variance were allowed to differ as a function of moderator M1 or M2.   
 
 Liability threshold 
model (Study II) 
For all binary traits under study, 
ACE and AE twin models were 
combined with a liability 
threshold model.  
For example, dementia is a 
dichotomous measure; one either 
has a diagnosis of dementia or 
does not. The liability threshold 
model assumes that binary traits 
are affected by numerous factors 
with small effects that sum up to 
a liability score. Thus, there is an 
Figure 5.1.4. Liability threshold model. 
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underlying normal distribution of liability for dementia in the population with one 
threshold for binary traits (for traits with ordinal groupings, there is more than one 
threshold). When a certain threshold is reached, i.e. when clinical symptoms of 
dementia appear and persist, it is at this cut-off when a non-case becomes a case. The 
further to the right of the liability threshold, the more severe the dementia (Figure 
5.1.4). 
Thus, with the appropriate tools genetically informative twin data are helpful for 
understanding genetic and environmental influences on phenotypic variation. 
 
 Latent Growth Curve Modeling (Study IV) 
Latent Growth Curve Modeling (LGCM) is a longitudinal analysis technique for estimating 
change (or specifically growth or decline) over time.116 It can also be thought of as a 
mixed model that estimates fixed and random (latent) effects.  
The first step of LGCM entails establishing the optimal fit of the model, that is, one that 
best captures the collection of individual change over time. This can be done by 
comparing the fit of two or more models based on, for example, Akaike Information 
Criterion (AIC) fit estimates. In Study IV, the fit of a one-slope model was compared to 
that of a two-slope model with retirement age as centering age. In the one-slope model, 
or the linear model, an intercept and a slope (Slope 1) was included, with Slope 1 defined 
as the rate of cognitive change per year spanning across the entire measurement period. 
In the two-slope model, also called a piecewise model or spline model, an intercept and 
two slopes (Slope 1 and Slope 2) were included, with Slope 2 defined as the additional 
rate of cognitive change per year after retirement age. Based on a comparison of AIC fit 
estimates (the smaller the better fitting), the two-slope model was determined to be 
better fitting for all cognitive factors. 
The second step is to include predictors as well as other covariates of interest into the 
model. This results in a conditional growth model since parameter estimates are now 
adjusted for covariates.  
In summary, fixed effects are represented by the mean intercept and the mean slopes, 
and random effects are the variance of individual trajectories around these means. 
Together, fixed and random effects provide a picture of growth (or decline) that takes 
into account between-individual differences and within-individual variation.  
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5.2 OVERVIEW OF METHODS BY STUDY 
 Study I – The prospective study on sleep characteristics and incident dementia 
5.2.1.1 Study population 
Study I explored the association between sleep-related characteristics and incident 
dementia while accounting for baseline cognitive function. The study base comprised 
like and unlike-sexed twins from the old and middle STR cohort who were born 1958 or 
earlier and who had participated in the SALT interview in 1998-2002. Since by design 
only SALT participants who were 65 and older at the time of interview (N=12,803) 
were administered questions about sleep, the age range of the study population at 
baseline was between 65-99 years, effectively truncating the cohort to those born 1933 
or earlier. The study population in Study I is illustrated in the flowchart in Figure 
5.2.1.1. Altogether, 11,247 individuals responded to at least one of the sleep questions, 
and 4,716 responded to all sleep questions. As mentioned earlier, some of the sleep 
questions were not administrated to all persons aged 65 and over due to funding 
considerations, hence the low response rate to all sleep questions. 
 
Figure 5.2.1.1. Flow chart of participant selection and exclusion process (Study I).  
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5.2.1.2 Study design 
Study I is a prospective population-based study. Participants were interviewed at 
baseline in 1998-2002 and followed until a dementia diagnosis (ascertained in the NPR, 
PDR, and CDR), death, or end of follow-up (December 31, 2014), whichever came first 
(Figure 5.2.1.2).  
 
Figure 5.2.1.2. Prospective cohort design with time-to-event data.  
 
5.2.1.3 Exposure and outcome measures 
Exposure: Six sleep-related measures (TIB, rising time, bedtime, sleep quality, non-
restorative sleep, and heavy snoring) were assessed as exposures. These measures were 
based on KSQ items included in the SALT interview. A TIB measure including daytime 
nap time was created for a sensitivity analysis.  
Outcome: Incident dementia. Dementia data were ascertained from register sources (the 
NPR, PDR, or CDR).  
5.2.1.4 Statistical analysis 
Cox proportional-hazards regression was performed to estimate HRs with 95% CIs for 
the associations between the 6 sleep characteristics and incident dementia. Age was the 
underlying time scale. Follow-up time, sex, education, and baseline cognitive functioning 
(TELE score) were adjusted for in final Cox models. Covariates for smoking, habitual 
alcohol consumption, physical exercise, BMI, type II diabetes, sleep medication use, NW 
status, cancer, CVD, and COPD were included in preliminary models, but dropped in final 
models due to unchanging estimates and to maintain model parsimony.  
Multivariable adjusted Cox models were also stratified by baseline cognitive status to 
assess how HR estimates of associations changed across ordinal levels of baseline 
cognition.  
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Co-twin control analysis on a sample of twins discordant for both exposure and outcome 
was performed to control for familial effects. These models were fitted to all twin pairs 
(to control for familial confounding), as well as to a subset of monozygotic twin pairs (to 
control for genetic confounding).  
Additional sensitivity analyses entailed Cox analyses using slightly differing study 
populations depending on exclusions based on follow-up time. 
In all models excepting the co-twin control model, cluster-robust standard errors were 
used to correct for dependence between pair members.  
Data analyses were performed in SAS 9.4 and STATA 13. 
 
 Study II – The twin study estimating genetic and environmental influences 
5.2.2.1 Study population 
Study II deals with quantifying genetic and environmental influences on phenotypes for 
late-life sleep and dementia, as well as testing for moderating effects of sleep on the 
genetic and environmental influences on dementia and AD. The study population in Study 
II is similar to that in Study I, with small differences in inclusion criteria (Figure 5.2.1.1 
And Figure 5.2.2.2).  
5.2.2.2 Study design 
Study II primarily uses a classical twin design to assess the extent to which genetic and 
environmental factors contribute to a trait. Using the structural equation modeling 
approach, variances for a trait can be decomposed into latent variables that represent 
unobserved genetic and environmental contribution. The prospective cohort study 
design was also employed in Study II to confirm the association between the sleep 
characteristics and incident dementia. 
5.2.2.3 Phenotypes 
The phenotypes assessed in Study II included incident dementia, incident AD, and six late-
life sleep characteristics. The sleep characteristics (TIB, rising time, bedtime, sleep 
quality, non-restorative sleep, and heavy snoring) are the same as those in Study I. 
Regarding the TIB measure, TIB was treated as a binary variable instead of a categorical 
variable. Thus, we had a long TIB variable which was grouped as ‘long TIB’ (>9 hours) 
versus ‘moderate TIB’ (≤6 to 9 hours). Short TIB was not assessed due to insufficient 
power. TIB was treated as such in Study II in order to comply with assumptions under 
the liability threshold model. The liability threshold model is necessary for converting 
binary or categorical data into a latent liability score.  
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Figure 5.2.2.2. Flow chart of participant selection and exclusion process (Study II).  
5.2.2.4 Statistical analysis 
Within-pair correlations were computed to get a sense of whether there were genetic 
influences for dementia, AD, and sleep traits. Quantitative genetic analysis, in the form of 
univariate AE and ACE twin models, were performed to estimate genetic influences 
(heritability) and environmental influences on the traits. AE models, compared to ACE 
models, were more parsimonious and generally fit the data better according to likelihood 
ratio test and AIC fit statistics.  
Cox proportional-hazards regression was done to estimate HRs of associations between 
the sleep traits and dementia (and to confirm the associations reported in Study I) as well 
as between the sleep traits and AD. Cross-twin cross-trait correlations, i.e. correlation 
between trait 1 (sleep) in one twin with trait 2 (dementia) in the co-twin, were computed 
and suggested limited genetic correlation between the sleep traits with dementia and AD.  
Based on Cox model and cross-twin cross-trait correlation findings, univariate ACE and 
AE twin moderation models were fitted to assess whether a given sleep parameter 
moderated the genetic and environmental effects on dementia and AD risk (Figure 5.1.3.) 
In other words, the moderation models assessed whether the phenotypic variance of the 
outcome (liability for dementia and AD) explained by genetic (A), shared environment 
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(C), and non-shared environment (E) differed by level of the moderator (sleep 
phenotype, namely long TIB and late rising).  
For all models, the estimation of the threshold of a trait, i.e. the means (continuous 
variable) or prevalences (binary variable) of a trait, was adjusted for age and sex. Data 
management was performed in SAS 9.4, and quantitative genetic analyses in OpenMx and 
mets packages in R 3.4.1.  
 
 Study III – The prospective study on SW and incident dementia 
5.2.3.1 Study population 
Study III examined the association between SW and incident dementia based on two STR 
cohorts: the STR-1973 cohort and the SALT cohort. The two study populations were 
analyzed separately in main analyses. As there was overlap of participants between the 
STR studies (N=8,904), the two were combined into one sample in sensitivity analyses.  
To ensure that there was sufficient job experience at the time of responding to the 
questionnaire, individuals younger than 30 years were excluded from the STR-1973 
sample (n=19,178), which was on average younger than the SALT cohort. 
As this study was concerned with incident dementia in relation to SW, individuals with 
prevalent dementia or baseline cognitive dysfunction were excluded, as were those who 
did not work or those who reported having worked shifts when they were younger than 
17, which may have been invalid responses. 
Compared to Study I and Study II, the study population in Study III was younger at 
baseline (mean 37.8 years, SD 5.4 in STR-1973; mean 58.5 years, SD 10.4 in SALT). Thus, 
the prevalence of dementia in Study III was lower (7.4% in STR-1973 and 4.8% in SALT).  
Subsamples of the STR-1973 and SALT cohorts participated in TwinGene and therefore 
had data on APOE genotype.  
Flow charts of the participant selection process based on the STR-1973 cohort are 
depicted in Figure 5.2.3.1a and the SALT cohort in Figure5.2.3.1b. 
5.2.3.2 Study design 
Study III employed a prospective population-based cohort design using time-to-event 
data (Figure 5.2.1.2). Participants in the STR-1973 cohort were followed from baseline in 
1973 until a dementia diagnosis, death, or end of follow-up in December 31, 2014. The 
median follow-up time was 41.2 years. Participants in the SALT cohort were followed 
from baseline in 1998-2002 until a dementia diagnosis, death or end of follow-up in 
December 31, 2014. The median follow-up time was 14.1 years. 
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Figure 5.2.3.1a. Flow chart of participant selection and exclusion process for the STR-1973 cohort 
(Study III).  
 
 
Figure 5.2.3.1b. Flow chart of participant selection and exclusion process for the SALT cohort 
(Study III).    
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5.2.3.3 Exposure and outcome measures 
Exposure: Status and duration of SW in general were assessed in the STR-1973 cohort. 
Status and duration of NW were assessed in the SALT cohort. 
Outcome: Incident all-cause dementia and AD were examined as outcomes in this study.  
5.2.3.4 Statistical analysis 
Cox models with age as the underlying timescale was applied to estimate HRs for 
dementia. A cluster sandwich estimator was used to correct for relatedness between 
members of a twin pair. Since the mean baseline age in the STR-1973 sample was 38 
years and 58 years in the SALT sample, there were a few individuals who received a 
dementia diagnosis under age 65. These cases were considered as early-onset familial 
cases. Instead of excluding these individuals from the sample, which would be like 
looking into the future, we allowed these individuals to contribute person-years as non-
cases up until the point they received the dementia diagnosis at an age younger than 65.  
Main analyses 
Two sets of main analyses using Cox models were conducted. In the first set of analyses, 
SW status and duration of SW were examined in relation to incident dementia. For this 
analysis, the STR-1973 cohort were followed from baseline in 1973. The second set of 
analyses examined NW status and duration of NW in relation to incident dementia. For 
this analysis, the SALT cohort were followed from baseline in 1998-2002. Age, sex, 
education, diabetes, CVD and stroke were controlled for in final models. Diabetes, CVD 
and stroke that occurred before a dementia diagnosis were allowed to vary with time; all 
other potential confounders were time-invariant. SW and NW duration variables were 
transformed into restricted cubic spline variables with three knots (1, 10, and 20 years) 
in Cox models.  
Sensitivity analyses 
Given the overlap of participants in STR-1973 and SALT, it was possible to combine SW 
information from both study sources. Three sensitivity analyses were undertaken to 
investigate how well the main findings would hold up depending on how the SW measure 
was treated. Based on a sample of individuals who had participated in both STR-1973 
and SALT, these were the different possible scenarios of SW exposure that were put forth: 
 Given that follow-up began in 1973, if one responded that they had SW in the 1973 
questionnaire and did not respond that they worked nights in SALT in 1998-2002, 
SW status was treated as time-varying. For those who had participated in STR-
1973 and not in SALT, SW was treated as a fixed variable.  
 Given that follow-up began in 1998-2002 at the time of the SALT interview, for 
those who had participated in both STR-1973 and SALT, the response in SALT 
determined the SW exposure duration if we assume that the duration reported in 
SALT included the duration reported in STR-1973. For those who participated in 
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only one of the studies, SW duration information was based on the study that one 
had participated in.  
 In the third scenario, given that follow-up time began in 1998-2002 when the 
SALT interview occurred, for individuals who participated in both STR-1973 and 
SALT, SW duration was the sum of SW durations reported in both studies. And 
again, for those who participated in just one of the studies, SW duration was based 
on whichever study one had participated in. 
There was also the matter of possible cohort effects, and thus a final sensitivity analysis 
was done that entailed restricting the SALT sample to include individuals born 1926-
1958, so as to be comparable to the STR-1973 sample born 1926-1958.  
Additional analyses 
In the genotyped subsamples, APOE status was include in Cox models. 
Similar to Study I, co-twin control analyses were applied to a sample of twins discordant 
for exposure (SW/NW) and outcome (incident dementia). The model was fit to all twin 
pairs (including DZs and MZs) as well as to a subset of MZ twin pairs.  
Data management was done in SAS 9.4 and data analyses in STATA 14.1. 
 
 Study IV – The longitudinal study on SW and cognitive aging 
5.2.4.1 Study population 
Study IV deals with the relationship between SW and normative cognitive aging. 
Participants were drawn from the IPT phase of the population-based SATSA. A total of 
859 individuals had participated in at least one out of nine IPT waves. Participants with 
dementia at baseline were excluded; for those who developed dementia later in the 
course of follow-up, data points after the diagnosis were dropped from the longitudinal 
data analysis. After exclusion criteria were applied, the resulting main sample with 
complete data included 595 participants.  
Of the 595 participants with data on any-type SW status (of whom 106 had SW history), 
a subset of participants born 1958 or earlier (n=320) had also participated in SALT and 
therefore had data on NW. All individuals who responded in SALT that they worked 
nights had also responded that they were shift-workers in SATSA (n=47). Additionally, 
there was a subsample of 77 men born 1936 and 1948 who had undergone military 
conscription when they were approximately 18-20 years of age and thus had data on 
early adult general cognitive ability. The flowchart of the study population is depicted in 
Figure 5.2.4.1. 
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5.2.4.2 Study design 
A longitudinal study design was used in Study IV. The main analytic sample of 595 
participants were followed up for a mean of 17.6 years (SD 8.8) during 1984-2012. 
 
 
Figure 5.2.4.1. Flow chart of participant selection and exclusion process (Study IV).  
5.2.4.3 Exposure and outcome measures 
Exposure: SW of any type was the exposure variable of interest in the full sample. This 
data came from baseline Q1 in 1984. A NW measure based on SALT data from 1998-2002 
was examined in a subsample analysis. A binary (yes/no) and categorical (0 years; 1-9 
years; 10-19 years; 20 or more years) measure of SW and NW were assessed. 
Outcome: Outcome measures included the mean cognitive performance at retirement age 
and the rate of cognitive performance change for five components (verbal, memory, 
spatial, and processing speed abilities).  
5.2.4.4 Statistical analysis 
The main analysis entailed a LGCM for estimating the effect of any-type SW on mean 
cognitive performance at retirement, and on change in cognitive performance across the 
mid to late adult life course. This was done for each of the five cognitive components. The 
LGCM includes an intercept and two slopes, which fitted the data better compared to a 
model with an intercept and one slope, as determined by AIC fit estimates (Table 5.2.4.4). 
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The intercept is fixed at retirement age, which is set as centering age. The first slope 
represents the rate of cognitive change per year across the whole measurement period, 
and the second slope represents the additional rate of cognitive change per year beyond 
retirement.  
 
Table 5.2.4.4. Comparison of AIC fit estimates for each cognitive factor  
 
 
Cognitive Measure 
One-Slope Model: 
Intercept and 1 slope 
Two-Slope Model: 
Intercept and 2 slopes 
AIC estimate AIC estimate 
Verbal 13,499 13,440 
Spatial abilities 14,110 14,060 
Memory 15,810 15,789 
Processing speed 15,193 15,119 
Global cognitive ability 12,865 12,564 
Note: Smaller AIC estimate indicates better fitting model.  
 
In a subsample of men, selection effects, i.e. the possibility that those with higher 
cognitive ability selected themselves into jobs entailing SW or not, were tested. T-tests, 
with a significance threshold set at p = 0.05, were used to compared mean early adult 
cognitive scores between shift-workers and day-workers, within low and high education 
groups.  
An additional subsample analysis was done to examine the association between NW and 
cognitive performance. 
Data management and analyses was done in SAS 9.4 (proc mixed command for LGCM). 
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6 MAIN FINDINGS AND DISCUSSION 
Table 6. Overview of the 4 studies within this thesis. 
Study I II III IV 
Aim Examine association 
between late-life 
sleep characteristics 
and incident 
dementia. 
Estimate heritability for 
sleep characteristics, 
dementia and AD, and to 
examine whether 
dementia-related sleep 
characteristics modify 
genetic influences on 
dementia and AD. 
Investigate association 
between mid-life SW 
and incident dementia. 
Estimate impact of 
mid-life SW on 
cognitive aging in 
late life. 
Data 
sources 
SALT, NPR, PDR, 
CDR 
SALT, NPR, PDR, CDR, 
SATSA, OCTO-Twin, 
Gender 
SALT, STR-1973,  
NPR, PDR, CDR, 
TwinGene 
SATSA, SALT, 
Conscription 
Register 
Study 
population 
Like and unlike-
sexed STR twins 
born 1958 or earlier, 
≥65 years and 
dementia free at 
SALT baseline 
Like and unlike-sexed 
STR twins born 1958 or 
earlier, ≥65 years and 
dementia free at SALT 
baseline 
Like and unlike-sexed 
STR twins born 1958 or 
earlier, ≥30 and 
dementia free at STR-
1973 or SALT baseline 
Like-sexed STR 
twins born 1958 or 
earlier, ≥50 years 
and dementia free 
at the first IPT 
occasion in SATSA 
Baseline 
age (Mean, 
SD) 
72.5 (SD 5.9) 72.6 (SD 6.0) STR-1973: 37.8 (SD 5.4) 
SALT: 58.5 (SD 10.4) 
58.2 (SD 10.5) 
Design Prospective cohort;  
co-twin control 
Prospective cohort; 
classical twin design 
Prospective cohort;  
co-twin control 
Longitudinal 
Follow-up 
time  
17 years 17 years STR-1973:42 years 
SALT: 17 years 
27 years 
Exposure Sleep characteristics 
(TIB, late rising, late 
bedtime, sleep 
quality, non-
restorative sleep, 
snoring) 
Sleep characteristics 
(TIB, late rising, late 
bedtime, sleep quality, 
non-restorative sleep, 
snoring) 
SW, NW SW, NW 
Outcome Incident dementia Incident dementia and 
AD 
Incident dementia 5 cognitive factors 
(verbal, memory, 
spatial, processing 
speed, global) 
Statistical 
methods 
Cox regression, 
ordinal logistic 
regression  
Cox regression, 
quantitative genetic 
analysis 
Cox regression  LGCM 
Covariates 
in final 
model 
Age, sex, education, 
and baseline 
cognitive function 
Age and sex Age, sex, education, 
diabetes, CVD, and 
stroke 
Age, sex, education, 
and occupational 
status 
Main 
findings 
Short TIB was 
associated with 40% 
increased dementia 
incidence based on 
full sample analysis. 
Long TIB and late 
rising were associated 
with higher dementia 
incidence (HR=1.47 
and HR=1.59, 
respectively) among 
those with baseline 
cognitive dysfunction, 
suggesting these 
characteristics were 
prodromal. 
Heritability was 47% for 
dementia and 54% for 
AD. For late rising and 
late bedtime, heritability 
was about 50%, and 
between 13-31% for long 
TIB, sleep quality, non-
restorative sleep, and 
snoring.  
While long TIB and late 
rising were associated 
with higher dementia 
incidence, these sleep 
traits did not moderate 
genetic effects for liability 
of dementia and AD. 
SW of any type 
(HR=1.36) and NW 
(HR=1.12) were 
associated with higher 
dementia incidence. 
Longer duration of SW 
and NW predicted higher 
dementia risk.  
Among APOE 4 carriers, 
those with ≥20 years of 
SW and NW had a 2 to 4-
fold greater dementia 
risk compared to day-
workers. 
SW of any type or 
NW during midlife 
did not affect the 
level of 
performance at 
retirement or the 
rate of change for 
any of the cognitive 
factors in later life. 
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6.1 STUDY I – THE ASSOCIATION BETWEEN SLEEP CHARACTERISTICS 
AND INCIDENT DEMENTIA 
 Main findings 
Participants had a mean baseline age of 72.5 years (SD 5.9) and were followed up for a 
median of 14.3 years. The incidence rate of dementia was 10.3 per 1,000 person-years 
in this study population aged 65 years and older. Out of 11,247 participants, 1,850 
(16.4%) cases of incident dementia were identified during the 17-year study period.  
 
Based on multivariable adjusted analysis of the full sample, TIB and rising time were 
associated with dementia incidence. TIB showed a U-shaped association with dementia 
incidence, such that short (HR=1.40, 95% CI=1.06-1.85) and long TIB (1.11, 95% 
CI=1.00-1.24) were related to higher rates of dementia. In a sensitivity analysis a TIB 
measure including daytime nap time was examined, but estimates remained 
unchanged. Those habitually rising from bed 8AM or later, compared to earlier risers, 
showed a 12% (95% CI=1.01-1.24) higher risk of dementia. Bedtime, sleep quality, 
non-restorative sleep, and snoring were not predictive of incident dementia.   
 
We then tested the association between sleep characteristics and incident dementia, 
stratified by baseline cognitive status. Among those cognitively intact at baseline, the 
association between short TIB and incident dementia became more pronounced, 
though with wider confidence intervals (HR=1.74, 95% CI=1.19-2.55). In those with 
poorest baseline cognitive status, long TIB (HR=1.47, 95%=1.08-2.00) and late rise 
time (HR=1.59, 95% CI=1.15-2.20) were associated with greater risk of dementia. 
Results from full sample analyses are illustrated in Figure 6.1a, and results from 
stratified sample analyses are illustrated in Figure 6.1b. 
 
Co-twin control analyses generally produced associations with wide confidence 
intervals that included the null, with no discernable pattern of findings, i.e. associations 
were not stronger based on a sample of only MZ twin pairs compared to a sample of all 
twin pairs. Thus, one cannot draw conclusions on whether familial factors confounded 
the associations between sleep characteristics and incident dementia.  
 
 
Figure 6.1a. Forest plot of HR associations between sleep characteristics and incident dementia based on 
full sample analysis. 
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Figure 6.1b. Forest plot of HR associations between sleep characteristics and incident dementia, stratified 
by baseline cognitive status. 
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 Discussion 
Study I extends prior studies on sleep characteristics in relation to subsequent risk of 
dementia. The U-shaped associations between TIB and increased dementia incidence 
agree with previous research showing positive associations between extreme sleep 
durations and elevated dementia risk.66 Mechanisms explaining the risk conferred by 
short sleep have been proposed. Studies based on mouse models have demonstrated 
that Aβ levels in brain interstitial fluid increase with longer time spent awake,117 and 
that rate of Aβ clearance is decreased during the wake state compared to the sleep or 
anesthetized state.118 Thus, short sleepers, who by default spend more time awake, may 
present with more amyloid accumulation that precedes amyloid plaque formation—a 
classic feature of AD. Short sleep has also been associated with subsequent ventricular 
enlargement119 and frontotemporal cortical thinning120 in those with dementia 
compared to healthy aged counterparts.  
 
The mechanism underlying long sleep and dementia risk is less clear. However, our 
study demonstrated that the association between long sleep and heightened risk of 
dementia was particularly strong in those exhibiting cognitive impairment at baseline, 
giving indication that long sleep may be marker rather than a contributor of 
pathological cognitive processes.  
 
Adding to a previous study that observed delayed peak circadian rhythm activity timing 
was associated with higher odds of mild cognitive impairment and dementia,121 the 
present study found that rising later in the morning compared to rising earlier was 
predictive of higher dementia incidence. On the other hand, later bedtime, which one 
would think goes hand in hand with later rising, was not significantly predictive. But 
considering there was variation in TIB, which was constructed from the variables for 
rising time and bedtime, it would make sense that early risers are not necessarily early 
sleepers. Rise time may be a better phenotypic representation of circadian rhythms as 
there are fewer external influencing factors and therefore more consistent than 
bedtimes within an individual. For bedtime, beyond the influence of circadian rhythms 
and sleep pressure are exogenous cues like artificial light and social activities. This may 
have led to a higher likelihood of reporting inaccurate bedtimes, which could lead to 
misclassification of the non-differential type, and thus have resulted in null findings.    
 
Our findings concerning sleep quality and dementia incidence agrees with previous 
studies that reported null findings119, 122, 123, but not with others that did find an 
association.124-126 This study also did not find snoring and sleep restoration to be 
predictive of incident dementia. Misclassification of exposure could be a possible culprit 
for the lack of association (see chapter 8 on methodological considerations).  
 
Overall, Study I showed that short and long TIB as well as late rising time among older 
adults were associated with greater dementia incidence in the following 17 years. The 
pattern of findings suggests that very long sleep and delayed rising represent 
prodromal dementia, whereas short TIB plays a contributory role for dementia. 
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6.2 STUDY II – SLEEP CHARACTERISTICS AND DEMENTIA: GENETIC AND 
ENVIRONMENTAL INFLUENCES 
 Main findings 
For the 10,894 participants in this study, the mean baseline age in 1998-2002 was 72.6 
(SD 6.0). During the study period, 2,135 (19.6%) developed dementia, of whom 1,456 
were AD cases (68.2%). 
 
The first part of Study II probed the balance between genetic and environmental 
contributions for a trait (dementia, AD, and late-life sleep traits). Within-pair 
correlations were generally twice as strong in MZ pairs as that in DZ pairs, indicating 
presence of genetic influences for all traits under study. For short TIB, although the 
within-MZ-pair correlation was high (.59) compared to the within-DZ-pair correlation 
(-.01), these coefficients were based only on 3 complete MZ twin pairs and 1 complete 
DZ twin pair concordant for short TIB. Given that there were so few observations with 
this phenotype, short TIB was not (and could not be) examined further in quantitative 
models. AE models provided further evidence of genetic influences on the traits (Figure 
6.2). Heritability for dementia, AD, late rising and late bedtime was approximately 50%, 
indicating substantial genetic effects for the dementia outcomes and chronotype-
related traits. For the other sleep traits of non-restorative sleep, sleep quality, and 
snoring, heritability ranged between 13-31%, characterizing the importance of 
environment factors for these sleep traits.  
 
 
 
 
Figure 6.2. AE components of variance with 95% CIs for dementia, AD, and sleep traits. 
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The second part of Study II investigated sleep measures as a moderator on the genetic 
and environmental influences on dementia and AD liability. Before performing twin 
moderation analysis to investigate this question, we confirmed the associations 
between long TIB (HR=1.19, 95% CI=1.08-1.82) and late rising (HR=1.11, 95% 
CI=1.00-1.22) with incident dementia, which were similar in magnitude to that in Study 
I. The sleep measures were also analyzed in relation to incident AD. Similar associations 
were observed (Table 6.2), wherein long TIB (HR=1.35, 95% CI=1.11-1.40) and late 
rising (HR=1.11, 95% CI=1.01-1.23) were associated with higher risk of AD. We also 
checked cross-twin cross-trait correlations, which were low – about .10 or less – and 
were not discernably higher in MZ twins than in DZ twins. This suggests minor or 
absence of additive genetic influences to the contribution of the covariation between a 
given sleep trait and dementia or AD, i.e. the two traits are unlikely to share common 
genetic roots.  
 
Table 6.2  
Associations between sleep measures and incident dementia and AD based on Cox models.  
 Dementia  AD 
 HR (95% CI) HR (95% CI) 
Time in bed 
Short (≤ 6 hours) 
Reference 
Long (> 9 hours) 
 
1.40 (1.08-1.82) 
1.00 
1.19 (1.08-1.31) 
 
0.99 (0.69-1.42) 
1.00 
1.25 (1.11-1.40) 
Rise time 
Earlier than 8AM 
8AM or later 
 
1.00  
1.11 (1.00-1.22) 
 
1.00  
1.11 (1.01-1.23) 
Bedtime  
Earlier than 11PM 
11PM or later 
 
1.00  
0.92 (0.83-1.03) 
 
1.00  
0.92 (0.83-1.03) 
Sleep quality index 0.93 (0.86-1.01) 0.93 (0.86-1.01) 
Non-restorative sleep index  0.92 (0.79-1.07) 0.92 (0.80-1.07) 
Heavy snoring 
No 
Yes 
 
1.00 
0.90 (0.79-1.03) 
 
1.00 
0.90 (0.79-1.02) 
Note: Model is adjusted for sex with age as the underlying timescale, with robust standard errors. Analyses 
of TIB, rise and bedtime were based on a sample of N=10,894. The sleep quality index, non-restorative 
sleep index, and heavy snoring were based on smaller samples of N=5,278, N=5,308, and N=4,686, 
respectively. Note: Higher scores on the sleep quality index and non-restorative sleep index indicate poorer 
quality or less restorative sleep, respectively. 
 
Since long TIB and late rising were associated with incident dementia and AD, these 
traits were assessed as moderators in separate moderation models. After implementing 
a rigorous procedure of ACE and AE model fitting which entailed comparing a number 
of nested models, we observed that models with moderation on the variance did not fit 
significantly better compared to models without moderation on the variance. Taking 
the late rising phenotype as an example, this means that the proportion of variance in 
dementia or AD attributable to genetic and environmental variance did not differ 
between late risers and early risers. Thus, we did not find evidence of moderation 
effects of long TIB or late rising on the genetic and environmental influences on liability 
of dementia or AD.  
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 Discussion 
Our heritability estimates of about 50% for incident AD and incident dementia is in line 
with those previous studies.3, 41, 42 Our findings concerning rising time and bedtime, 
together with findings from previous studies on diurnal preference,127 suggest that 
chronotype-related phenotypes are equally influenced by genetic and environmental 
effects. Heritability for late bedtime was slightly lower than for late rising, which we 
suspect may be due to random error. For instance if we assume that, within an 
individual, bedtime is more susceptible to exogenous cues, i.e. light emitted from a 
smartphone or laptop, this may contribute to more inter-individual variation in 
bedtimes. Comparatively, rise times, other than perhaps waking up to use the 
bathroom, may be more driven by circadian rhythms. For the other late-life sleep traits 
under study—long TIB, sleep quality, non-restorative sleep, and heavy snoring—our 
study and others128-131 point to the relative importance of environmental factors in 
explaining the phenotypic variances.  
This is the first study to examine sleep habits, specifically long TIB and late rising, as 
moderators of genetic influences on dementia and AD liability. As we did not observe 
moderation effects, this indicates a lack of gene-environment interaction influencing 
liability of AD or dementia. Taken together with findings from Study I, long TIB and late 
rising are unlikely factors augmenting dementia susceptibility, but rather prodromal 
manifestations of preclinical dementia. Short TIB, on the other hand, appeared to fit the 
role of a risk factor for dementia and AD; unfortunately, too few observations with short 
TIB meant moderation analysis for short TIB and dementia/AD was unachievable. 
 
  
 48 
6.3 STUDY III – THE ASSOCIATION BETWEEN SW AND INCIDENT 
DEMENTIA 
 Main findings 
For the STR-1973 cohort, the mean baseline age of the 13,283 participants aged 30 
years and older was 37.8 years (SD 5.4). The incidence rate of dementia was 2 per 1000 
person-years, and a total of 983 (7.4%) incident dementia cases were identified during 
the study period between 1973 and 2014 (median follow-up time of 41.2 years (range 
0.01 to 42.0 years) for the STR-1973 cohort.  
 
For the SALT cohort (N=41,199), the mean baseline age was 58.5 years (SD 10.4). In this 
sample, the incidence rate was 3.6 per 1000 person-years, and a total of 1,979 cases 
(4.8%) were identified between 1998 and 2014. The lower incidence proportion 
detected in the SALT sample is likely owed to the fact that individuals with baseline 
cognitive dysfunction were excluded from the SALT sample.  
 
Having ever been exposed to SW or NW was associated with increased dementia rates 
(Figure 6.3). For SW, a very slight attenuation was noted in the (final) model 
additionally adjusted for diabetes, CVD and stroke (HR=1.36, 95% CI=1.15-1.60) 
compared to the model adjusted only for age and sex (HR=1.41, 95% CI=1.19-1.66). 
Adjustment for these cardiometabolic factors did not attenuate the association for NW 
and dementia incidence.  
 
 
Figure 6.3. HR estimates of associations for SW and incident dementia from main analyses 
based on the STR-1973 cohort and the SALT cohort. 
 
Sensitivity analyses based on SW measures derived from SW and NW information from 
both STR-1973 and SALT yielded similar estimates, with HRs ranging from 1.13 to 1.18, 
with confidence intervals of similar width and not including the null. Further, similar 
HR estimates were produced from a sensitivity analysis of the SALT cohort restricted 
to those born after 1925 (in an effort to be more comparable to the STR-1973 cohort).  
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Duration of SW and NW showed modest dose-response associations with dementia 
incidence, with longer number of years of SW or NW conferred higher dementia risk 
(Figure 6.4 and Figure 6.5, respectively). In Figure 7.5, which is based on the STR-1973 
sample, we see the gradual increase in dementia rates with increasing duration of SW. 
The risk drops slightly just shy of 20 years SW duration, which we suspect is ascribed 
to fewer observations having so many years of SW exposure.  
 
 
Figure 6.4. Cubic spline model for the association between SW duration and incident dementia, based on 
the STR-1973 sample (N=13,283), with the sample distribution of the total number of years of SW. Model 
adjusted for age, sex, education, diabetes, CVD and stroke.  
 
 
Figure 6.5. Cubic spline model for the association between NW duration and incident dementia, based on 
the SALT sample (N=41,199), with the sample distribution of the total number of years of NW. Model 
adjusted for age, sex, education, diabetes, CVD and stroke. 
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Findings from interaction analyses based on genotyped subsamples of APOE gene 
polymorphism with SW status and duration are shown in Figure 6.6, and with NW 
status and duration in Figure 6.7. An interaction between APOE 4 with NW but not 
with SW with regards to incident dementia was observed. In the APOE 4 carrier group, 
NW compared to day work was associated with a 41% (95% CI=1.08-1.92) increased 
hazards of dementia. 
  
  
Figure 6.6. HR estimates of associations. Interactions of SW and SW duration with APOE. 
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Figure 6.7. HR estimates of associations. Interactions of NW and NW duration with APOE. 
 
The interaction effect was even more apparent when examining SW duration and NW 
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Thus the 4-fold risk effect observed in the STR-1973 subsample analysis may have been 
specific to NW.   
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compared to that from the within-pair analysis fitted to all twin pairs (HR=1.12, 95% 
CI=1.01-1.23) and cohort level analysis (HR=1.28, 95% CI=1.00-1.64).  
With regards to the co-twin control findings, the attenuation in associations in the MZ 
subset (compared to that in cohort level analyses) suggests potential familial 
confounding. However, since co-twin control confidence intervals were wide and 
overlapping with those from cohort level analysis, the findings may not be wholly 
reliable.    
 Discussion 
To the best of our knowledge, there has so far only been one previous study that has 
investigated the association between SW and risk of dementia. In that study, which was 
based on a sample of 4,766 men from the Copenhagen Male Study who, the authors did 
not observe an association between SW (defined as SW including NW) and risk of 
dementia,132 which is contrary to our study’s findings. A possible explanation for the 
divergent findings may be due to the lower life expectancy since 1980 in Danes, 
particularly Danish men, compared to Swedes for practically all age groups and birth 
cohorts.133, 134 Thus it is possible that Danish men may not be living long enough due to 
dying from other causes such as lung cancer or heart disease to a greater extent than 
Swedes of either sex. Our results are in line with an earlier study based on a Danish 
cohort of 18,015 female nurses, also of prospective design, which reported that evening 
and rotating SW compared to day work was associated with a 4-fold and 5-fold risk, 
respectively, of mortality due to all-cause dementia including AD.135 A difference 
between the two Danish studies is that one was based on a sample of men, and the other 
of women. In our final models, sex was controlled for, though there was hardly any 
difference in findings regardless of whether or not sex was included as a covariate. 
Nevertheless, including both men and women in the study population offers greater 
generalizability of findings.  
Plausible mechanisms underlying the risk of dementia conferred by SW may have to do 
with forced desynchronization of the circadian clock, thereby eliciting a cascade of 
effects. Sleep restriction has been shown in Study I and other previous research66 to be 
linked to increased risk of dementia. Perturbations of our internal circadian clock 
caused by altered sleep times and eating schedules may have deleterious effects on 
metabolic and endocrine functions, and present as reduced glucose tolerance and 
diabetes.136, 137 In diabetes, high glucose levels increase oxidative stress, which is toxic 
to neurons, and high insulin levels may impair Aβ clearance from the brain.138 Relatedly, 
shift work via circadian rhythm disturbance may break down vascular integrity; this 
hypothesis is supported by a highly controlled laboratory study that showed circadian 
misalignment per se increased blood pressure and inflammatory markers such C-
reactive protein and interleukin-6 over a 24-hour period in healthy adults.139 Heart 
disease, stroke and cardiovascular risk factors, including diabetes, manifesting during 
midlife have been linked to future development of dementia.140 Working on a shift 
schedule has been shown to instigate changes in lifestyle like reduced physical 
activity.141 Social and domestic life tends to suffer in shift-workers, which can lead to 
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poorer psychological wellbeing.142 Such lifestyle factors and social aspects can bring 
about or exacerbate cardiometabolic factors, and in turn, lead to poorer cognitive 
profile. The slight attenuation upon adjustment for diabetes, CVD and stroke suggests 
these factors may partially mediate the association between SW and dementia risk.  
The mechanism explaining the interaction effect between APOE and SW/NW with 
respect to dementia risk is unknown, but one could speculate. A hypothesis is that SW, 
perhaps via restricted sleep, may modify the effect of APOE genotype on AD and all-
cause dementia. APOE has an important function binding and transporting lipids,143 and 
the APOE Ԑ4 isoform, a well-established genetic risk factor for sporadic AD, has been 
shown to be less efficient at binding cholesterol and implicated in impaired Aβ 
clearance.144 One previous study reported that better sleep consolidation—the extent 
to which sleep is interrupted (or not interrupted) by arousals—attenuated the 
influence of APOE Ԑ4 on risk of AD and neurofibrillary tangle pathology.145 In Study III, 
while one of the aims was to examine short sleep as a moderator of genetic influences 
on dementia and AD liability, we were ultimately hindered by a lack of data on complete 
twin pairs concordant for short sleep.  
Evidence on the association between SW and risk of dementia is still preliminary, and 
as this is the one of the first studies to report a connection between shift work and 
increased incidence of dementia, further research on this topic is warranted. 
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6.4 STUDY IV – THE IMPACT OF SW ON COGNITIVE AGING 
 Main findings 
In this longitudinal study, 595 participants (mean age at baseline in 1984=58.2, SD 
10.5) were followed for up to 27 years (median of 19.2 years). Of these, 106 (18.3%) 
individuals were identified as shift-workers. SW was not associated with mean 
cognitive performance at retirement or with cognitive change before and after 
retirement for any of the 5 composite factors (verbal, spatial, memory, processing 
speed, global) even after adjustment for age, sex, manual work status, and education. 
Duration of SW was also not associated with cognitive level and rate of change.  
Findings were similar when NW was examined in relation to cognitive performance 
level and rate of change based on analyses of a subsample (n=320; mean age at baseline 
in 1984=55.0, SD 8.8; mean age at SALT interview in 1998-2002=69.2 years, SD 8.7), 
of whom 47 (14.7%) were identified as night-workers. Regarding the 47 shift-workers 
who indicated that they worked nights, the mean age at the time of the SALT interview 
in 1998-2002 when they responded about NW history was 69.7 (SD 8.7) and the mean 
duration of NW reported was 14.4 years (SD=12.3). Thus, one can infer that exposure 
to NW for these 47 individuals was during mid-life. LGCM estimates of associations with 
standard errors are displayed in Table 6.4. Trajectories of cognitive factors plotted on 
LGCM-based scores estimated as a function of shift work are illustrated in the left 
column of Figure 6.8.  
We noted an interaction between SW and education on cognitive performance at 
retirement for all 5 cognitive factors. As shown in the right column of Figure 6.9, among 
those with higher levels of educational attainment, day-workers scored higher on 
average for all cognitive factors at retirement than shift-workers, which was expected. 
Curiously, in the group with less education, day-workers performed relatively poorly 
compared to shift-workers. The reasoning behind this latter finding was not 
immediately apparent, so to dig deeper we performed sensitivity analyses based on a 
subsample of 77 men who had data on early adult cognitive ability. This subsample 
analysis revealed that within the group with lower education (n=33), the mean early 
adult cognitive ability was higher for shift-workers (n=8; mean=19.4, SD 5.4) than for 
day-workers (n=25; mean=16.8, SD 5.3) (p=0.23). Within the group that was higher 
educated (n=44), the early adult cognitive scores were lower for shift-workers (n=10; 
mean=19.5, SD 5.6) than for day-workers (n=34; mean=22.0, SD 5.23). Although the 
subsample findings were not significant at an alpha level of .05, the pattern of findings 
suggests selection effects were present. For instance, those with lower education but 
higher intelligence may have selected jobs with low education requirements that were 
more mentally demanding, and such jobs may have involved shift work. Moreover, the 
fact that there was no interaction on the slopes, i.e. the rate of cognitive change, which 
captures within-person change, adds to the suspicion that the interaction findings were 
driven by selection effects 
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Table 6.4. Latent Growth Curve Model estimates of association between SW or NW with level and change in cognitive performancea 
 
 
 
 
Effect 
 
 
Verbal Spatial Memory Processing Speed Global 
Est. SE Est. SE Est. SE Est. SE Est. SE 
 Shift work†           
InterceptRA 0=No (Reference) 51.66*** 2.16 64.66*** 2.73 50.86*** 2.59 59.78*** 2.49 57.99*** 2.33 
 1=Yesb 1.33 0.86 0.01 1.07 0.88 0.99 0.01 0.97 0.35 0.93 
Linear AgeS1 0=No (Reference) -0.04 0.24 0.85* 0.34 0.64 0.40 0.69 0.37 0.57* 0.24 
 1=Yesc 0.04 0.07 -0.06 0.10 -0.18 0.11 -0.13 0.12 -0.12 0.07 
Linear AgeS2 0=No (Reference) 0.69* 0.28 -0.46 0.43 0.26 0.48 -0.31 0.45 0.26 0.31 
 1=Yesd -0.12 0.09 0.12 0.14 0.29 0.15 0.21 0.14 0.20 0.10 
 Night work‡            
InterceptRA 0=No (Reference) 46.83*** 2.71 58.62*** 3.69 50.04*** 3.32 59.03*** 3.25 54.12*** 3.14 
 1=Yesb 0.43 0.14 -2.00 1.55 0.94 1.36 -1.67 1.34 -0.92 1.32 
Linear AgeS1 0=No (Reference) 0.23 0.30 0.46 0.45 0.30 0.53 0.82 0.48 0.38 0.30 
 1=Yesc -0.03 0.08 0.04 0.13 -0.16 0.14 -0.20 0.14 -0.12 0.09 
Linear AgeS2 0=No (Reference) 0.23 0.35 0.30 0.56 0.78 0.63 -0.42 0.57 0.49 0.38 
 1=Yesd -0.02 0.11 0.04 0.18 0.30 0.19 0.24 0.18 0.17 0.13 
Abbreviations: Est., estimate. SE, standard error.  
Significance levels: *p<0.05, **p<0.01, ***p<0.001. An asterisk for InterceptRA indicates the value is significantly different from 0. An asterisk for slope 
(Linear AgeS1 or Linear AgeS2) indicates the slope is significantly different from 0.  
†Associations between SW with cognitive level and change based on full sample (N=595). 
‡Associations between NW with cognitive level and change based on subsample (N=320).  
a All models are adjusted for baseline age, sex, education, and occupational status. 
b Effect of SW or NW on mean performance level (InterceptRA) at retirement age compared to reference. 
c Effect of SW or NW on rate of change per year in cognitive performance across the entire measurement period (Linear AgeS1) compared to reference. 
d Effect of SW or NW on additional rate of change per year in cognitive performance after retirement age (Linear AgeS2) compared to reference. 
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 Discussion 
Earlier studies that have examined the association between SW and later cognition in 
middle and older-aged adults have so far provided different pieces of evidence. The 
findings revealed in the present study are consistent with a previous prospective study 
based on the Nurses’ Health Study cohort that did not find an association between mid-
life SW history with later life cognitive status and decline.84 In contrast, two other studies 
reported positive findings for the association between SW and cognitive performance. A 
French study reported that current or past exposure to rotating SW versus never having 
been exposed to SW was associated with lower cognitive scores for memory, speed, and 
global performance.83 However, this was based on differences in mean cognitive 
performance scores and not on differences in rate of performance change. This makes the 
results less clear-cut since mean differences does not capture within-individual variation 
over time. The investigators also observed that among former shift-workers, those who 
had stopped working shifts earlier performed better on cognitive tests than those who 
stopped working shifts more recently.83 A recent Swedish study using a cross-sectional 
design reported similar findings to the French study. Recent former shift-workers who 
had worked shifts within the past 5 years as well as current shift-workers demonstrated 
poorer executive cognitive function compared to day-workers; but no differences in 
executive cognitive function was observed between former shift-workers who had 
stopped working shifts more than 5 years ago and day-workers.146 Altogether, this would 
suggest that shift work may have acute and possibly reversible adverse effects, but not 
long-term effects if one stops working shifts.   
A general difference from Study III is that earlier studies did not account for dementia 
and thus cannot rule out the potential effect of underlying pathological processes. We 
acknowledge that such processes cannot be entirely ruled out in Study IV given the long 
preclinical phase dementia (and that in some cases underlying neuropathology does not 
guarantee dementia development), but efforts to study normative cognitive aging were 
made by excluding those with baseline dementia as well as observation points relating to 
occasions following a dementia diagnosis. 
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7 GENERAL DISCUSSION 
A considerable amount of research has been undertaken to gauge how aspects of sleep 
relate to later life cognition and dementia. However, there is variation in sleep 
characteristics studied, with more investigations on sleep quantity, quality and 
disordered breathing, and less on chronotype-related features such as rising time and 
bedtime. Moreover, findings have been inconsistent among studies. Comparatively 
lacking is the research done on SW and its long-term cognitive effects. The studies in this 
thesis add to the discussion on the role of sleep as well as SW in later life cognition. 
In Study I, after accounting for baseline cognition, short TIB fit the role of a risk factor for 
dementia while long TIB and late rising appeared to signify prodromal dementia. Short 
TIB as a risk factor may be interpreted as such: short TIB may initiate development of 
dementia, or that it may accelerate progression of existing pathology. We also wondered 
if the association between short TIB and dementia could be explained by genetic factors 
in common to both traits, or if short sleep perhaps potentiated genes influencing 
dementia risk. All scenarios are biologically plausible. The intention was to examine the 
last question using quantitative genetic models in Study II; unfortunately, this was not 
possible as only 3 MZ twin pairs were concordant for short sleep. But since there are MZ 
twins discordant for short sleep, it cannot only be genetics influencing one to have short 
sleep. Clearly more research, particularly with larger samples, is needed.  
Long TIB and late rising, on the other hand may be markers of incipient dementia. Rather 
than being risk factors in the sense that long TIB and late rising per se would cause 
development of dementia, which is not unthinkable but mechanistically mysterious, 
these characteristics of sleep in older individuals may be neurobehavioral manifestations 
of preclinical dementia. The lack of moderation of long TIB and late rising on the genetic 
influences on dementia liability as shown in Study II supports the premise of these sleep 
traits as markers of ongoing pathological processes. Delayed rising may signify circadian 
rhythm irregularities and fragmented sleep (that is perhaps underestimated by self-
report), which are more prevalent and severe in patients with dementia compared to 
healthy controls,147-149 and are implicated in neurodegenerative processes.148 Long TIB, 
too, may be driven by early neurodegeneration. This was suggested by a study that 
showed prolonged sleep duration of more than 9 hours (relative to sleeping 6-9 hours) 
was associated with smaller total cerebral brain volume.150 Long sleep and late rising may 
also be due to disordered breathing during sleep, depression, alcohol consumption, and 
underlying disease processes.151 However, adjustment for various potential confounders 
such as depression, COPD, CVD, cancer history, type II diabetes, BMI, smoking, alcohol 
use, sleep medication use, and NW did not influence the association between long TIB 
and dementia incidence. Having found an effect of NW on risk of dementia in Study III, it 
was at first curious that adjustment for NW did not significantly influence the association 
between the investigated sleep characteristics and incident dementia. However, since 
sleep was assessed at age 65 or beyond, sleep habits may have changed before and after 
retirement. Perhaps it would have been a different story had we examined sleep habits 
during midlife with respect to dementia risk, and adjusted for NW, or vice versa.  
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Directly impacting sleep is SW, which is a term with fairly negative connotations, likely 
due to the myriad of physical symptoms and disorders that have been reported to be 
associated with this type of work schedule. As for cognitive effects, it is virtually 
undisputed that a shift schedule, particularly when including night shifts, acutely impairs 
cognitive performance—and certainly, most of us can recognize that disoriented feeling 
and loss of concentration that comes with jetlag. Considering this, it is rather surprising 
how sparse the literature is on the chronic cognitive effects of SW. This is where Study III 
and Study IV come into play.  
The findings in Study III and Study IV were illuminating, but did not perfectly align with 
expectations—though such an occurrence rarely happens in research it seems. In Study 
III, SW and NW during midlife were associated with increased incidence of dementia. In 
Study IV, based on a sample of participants with no dementia and with data points from 
the time a person developed dementia excluded, we found that midlife SW did not 
influence age-related cognitive change. Findings from earlier research on the long-term 
cognitive effects of SW have also been somewhat conflicting. The point of divergence may 
lie in the concept of SW recency. In previous studies, associations between SW and 
cognitive performance were particularly strong when the focus was on ‘recent shift-
workers’—that is, shift-workers who had worked shifts during the previous 5 years. 
Importantly, former shift-workers who had ceased working shifts at least 5 years ago 
showed similar cognitive performance levels compared to those who had never worked 
shifts.83, 146 And that among those with SW history, former shift-workers who exited SW 
within the past 5 years performed better than those who had exited SW earlier.83 Data on 
recency of SW exposure as well as longitudinal data on SW were not available in Study III 
and Study IV, and represents a limitation as we could not account for the possible 
reversibility factor of SW. Differences in cognitive change tend to be subtle, and is all the 
more difficult to capture in smaller samples.  
But how do the findings in Study IV (where there was no evidence of an association 
between SW and late life normative cognitive functioning) reconcile with those we saw 
in Study III (where we saw a positive association between SW and risk of dementia)? The 
possible reasons for the divergent findings are listed as follows: 
 Duration of SW – Longer duration of SW was associated with modestly higher 
dementia incidence (Study III). If we expect a small effect size of long SW duration on 
cogntive change, the SATSA sample and the number of shift-workers with 20+ years 
of SW history in this sample may not have been large enough to capture small effects 
(Study IV). In Study III, differences in SW duration might also explain why the risk 
effect of ‘general’ SW history (measured in 1973; mean STR-1973 cohort baseline 
age=38 years) was larger than that of NW history (measured in 1998-2002; mean 
SALT cohort baseline age=58 years). Some of those with a SW history in 1973 likely 
continued working shifts after the measurement timepoint, meaning they might have 
been exposed to SW for well beyond 20 years and thus showed higher risk of 
dementia.  
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 Cohort effects and riskiness of SW – The type of schedule (counterclockwise 
rotation or permanent night shifts vs. clockwise rotation, for example) together with 
fewer regulations surrounding SW might have driven risk of dementia upwards in 
the STR-1973 cohort compared to the later SALT cohort. This, in addition to other 
cohort effects (famine, influenza outbreak, poorer healthcare, et cetera) could also 
explain why the risk estimate of SW history (based on the STR-1973 cohort) was 
higher than that of NW history (based on the SALT cohort). 
 Age at exposure to SW – We did not have information on age at exposure to SW, but 
if we assume those with 20+ years of SW also were those who worked shifts when 
older, it could be that exposure to SW at an older age is riskier than exposure to SW 
at a younger age. This premise is supported by an earlier study based on the Nurse’s 
Health Study cohort that suggested that working night shifts before age 25 was 
associated with a more adverse risk profile for chronic diseases compared to night 
shift work later in life.152 Closely related is recency of SW exposure, which was 
associated with cognitive performance in previous studies. Perhaps those who were 
still working shifts were likely those exposed to SW at a later age, and that those who 
stopped working shifts were liklely those who stopped SW at an earlier age. So one 
might wonder how those who worked shifts for 20 years in total until the age of 65 
fared in terms of cognitive performance and dementia risk compared to those who 
worked shifts for 20 years in total until the age of 45 and then switched to day work.  
 Differential impact of SW on normative cognitive aging versus pathological 
cognitive aging – This is hinted by the interaction findings of SW*APOE genotype 
with respect to risk of dementia (Study III), which points towards SW exacerbating 
underlying genetic vulnerability, not unlike one of the hypothesized mechanisms 
explaining how short TIB may contribute to greater dementia incidence (Study I). 
While it is an intriguing thought that there may be a differential impact of SW on 
pathological versus non-pathological cognitive decline, testing this hypothesis is not 
straightforward since it is possible that individuals who do not outwardly exhibit 
cognitive decline may have underlying AD-like pathology.  
 The trifecta – What if we are not seeing an effect of SW on cognitive aging because to 
see an effect would require: a) long duration of SW, b) exposure to SW at older age, 
and c) being APOE Ԑ4 positive. This is perhaps a too simplistic reasoning, and there 
are likely other factors at play, but dementia and cognitive aging are multifactorial 
processes, so wouldn’t it make sense that these components together would drive the 
risk for dementia upwards (and perhaps accelerate non-pathological cognitive 
decline)?  
When taken together, perhaps Study III and Study IV are not contradictory, but rather 
complementary. The saying is trite, but truly, more studies are needed to better 
understand the role of sleep and SW in dementia and cognitive aging. Overall, the findings 
from epidemiological studies within and beyond this thesis paint a complex picture of 
how sleep and SW relate to later life cognition—But what one can take away is this: A 
confluence of factors contribute towards or act as markers of risk of dementia and 
cognition in old age; among these may very well be SW and atypical sleep. 
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8 METHODOLOGICAL CONSIDERATIONS 
All studies in this thesis utilized information from well-established population-based 
cohorts. The possibility of following participants on disease and vital status via register 
linkage represents a major strength of these studies. Nevertheless, epidemiological 
research is not without limitations. Some methodological issues were brought up in the 
general discussion within the last chapter. In this chapter, methodological weaknesses 
common in epidemiological studies are acknowledged; by doing so, we may improve 
upon future scientific work.  
8.1 STUDY POPULATION, SELECTION BIAS, AND GENERALIZABILITY 
Findings from population-based cohort studies can be generalized to the broader 
population as the selection of study participants is assumed to be random. Further, in 
the older birth cohorts of the STR, the willingness to participate in studies was higher 
than it is today. However, selection bias may still occur, particularly in studies of aging 
where individuals not only need to be in good enough health and willing to participate, 
but also need to have survived to a certain age to qualify for study inclusion. During the 
recruitment of the cohorts, it is likely that non-responders were older and in poorer 
health than responders, which would result in a study population that is healthier than 
the general population.153   
 
A comment on the slight study population differences in Study I and Study II:  
 
Although both Study I and Study II were based on the SALT cohort, study populations 
were not identical due to differences in exclusion criteria. Those who received a 
dementia diagnosis within 3 years proximal to baseline were excluded in Study I. 
However, sensitivity analyses were performed on samples that excluded those who 
developed dementia within 1 year, 2 years or 4 years from baseline, and results 
remained unchanged. Thus, in Study II, we did not exclude individuals with short 
follow-up time. Another difference between the two studies was that we decided to 
supplement register data on dementia diagnoses with dementia data from the STR sub-
studies of aging in Study II (which was the last study performed, chronologically). In 
the STR sub-studies, there were some who screened positive for dementia but did not 
participate in the clinical work-up; since dementia status for these persons was 
uncertain, they were excluded. Reassuringly, no matter which study population the 
analyses were based on, HR estimates of associations between sleep and incident 
dementia remained stable. 
8.2 CONFOUNDING AND REVERSE CAUSATION 
As with any observational study, confounding is a major concern. In each of the studies, 
we have taken care to adjust for potential confounders. Many of the times, the final model 
is not one that includes as many covariates as possible, but one that includes those based 
on subject matter knowledge; these covariates are generally the ones that do influence 
the association when tested in a statistical model.   
 62 
All the studies in this thesis aimed to understand the effect of sleep or SW on cognitive 
aging and risk of dementia, which implies a direction of causation. Assessing causality is 
especially challenging when the outcomes of interest are long-term processes, and even 
more so for dementia for which the preclinical stage is unknown.  
The same applies for SW and late life cognition—does working shifts lead to poorer 
cognitive function in late life, or does cognitive ability lead one to select a job with SW and 
is thus what predicts late life cognitive function? In Study IV, there was that peculiar 
interaction between SW and education, wherein lower-educated shift-workers showed 
better late life cognitive performance than lower-educated day-workers. Selection effects 
were suspected, and a sensitivity check indicated that early adult cognitive ability was 
higher in lower-educated shift-workers than in lower-educated day-workers (and also 
that early adult cognitive ability was higher in higher-educated day-workers than in 
higher-education shift-workers).  
With regards to SW and dementia, it does not seem logical that dementia would cause 
SW—but confounding is a major issue. Is it the adverse effect of SW or is it individual 
factors affecting one to work shifts that are associated with risk of dementia? What drives 
one to work shifts may be tied to SES, for example. Thus, SES indicators such as education 
and manual work status were adjusted for in models.  
8.3 POTENTIAL MISCLASSIFICATION 
Misclassification of dementia 
A limitation of Study I, Study II, and Study III has to do with the fact that dementia was 
identified from Swedish health registers, which could result in misclassification of 
dementia. Since only inpatient and outpatient data were included in the NPR, but not 
primary care data, the cases captured in the register may have been the more severe 
cases and persons receiving their diagnoses at younger ages as these cases may have been 
more likely to have been admitted to a hospital or require specialist care. In terms of 
detection of cases of dementia, the NPR and CDR combined have moderate sensitivity 
(63%) and high specificity (99.8%).106 That is, there are a moderate number of false 
negative cases, i.e. moderate probability of detecting dementia cases in registers—and a 
very low number of false positive cases, i.e. a high probability of detecting non-cases in 
registers. Misclassification of dementia due to low sensitivity, if unrelated to the 
exposure, would bias the association towards the null. A higher degree of 
misclassification was observed for differential diagnoses of dementia than for all-cause 
dementia, which was a primary reason for why all-cause dementia was examined as the 
outcome of interest in the relevant studies within this thesis. Dementia data were also 
pulled from the PDR. As of yet there has not been a validation study of dementia identified 
via the PDR, though anti-dementia drugs are highly specific for the treatment of AD 
(symptoms). However, it is possible dementia medications were prescribed to persons 
with mild cognitive impairment, which may have decreased the specificity of dementia 
diagnoses based on all three registers.  
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In Study II (which was chronologically the last study performed) we retrieved data on 
dementia not only from registers but also from four STR sub-studies, and the clinical 
dementia diagnoses available in these sub-studies were the reference gold standard the 
register-based diagnoses were compared against.106 As mentioned earlier, findings 
remained stable regardless of slight differences to the analytic sample or if dementia 
status was based on only register data or if it was supplemented with data from STR sub-
studies. The poor capture rate of the registry-based diagnoses may also have led to 
inflation of the non-shared environment term and thus contributed to the somewhat 
lower heritability estimates than previously reported based on the STR data. 
Given the insidious onset of dementia, it is also worth mentioning that age of dementia 
diagnosis does not necessarily indicate age of dementia onset. Indeed, the long preclinical 
and asymptomatic stage of AD would certainly suggest that there is a delay between age 
at onset and age at diagnosis. In Study I, this delay was accounted for when we tested 
associations on different samples based on different follow-up time criteria. 
 
Misclassification of sleep 
We cannot rule out the possibility of misclassification of sleep characteristics which 
were based on self-reported data. While subjective measures of sleep correlate with the 
corresponding objective measures of sleep, the correlation is not perfect.154 All sleep 
characteristics assessed had to do with habitual sleep experiences during the past 6 
months. Recalling bedtimes might have been trickier as bedtimes are more likely to be 
determined by exogenous factors while rising times serve as a better indicator of 
endogenous circadian rhythms. Thus, self-reported bedtimes may have been more 
susceptible to random error, and thus resulted in null associations with dementia risk. 
The sleep quality and non-restorative sleep indices have been shown to have good 
criterion validity and internal consistency,111 but as these were based on self-reported 
data there is still a possibility of random measurement error. The measure for snoring 
(yes/no) was admittedly a crude measure for capturing snoring status and particularly 
sleep-disordered breathing, and thus may have led to non-differential misclassification, 
which in turn contributed towards null findings.  
 
Misclassification of SW 
SW history and duration of SW history was assessed at a single measurement occasion 
(baseline), which may have led to misclassification of SW history status and length of SW 
exposure. This is perhaps less of an issue for the ever/never SW measure as day-workers 
were probably unlikely to switch to a SW schedule at a later age, but more problematic 
for duration of SW since some shift-workers likely continued to work shifts beyond 
baseline. To decrease the risk of misclassification, in Study III we utilized information 
about SW status and duration measured at different time points from two study sources, 
thereby allowing for SW status to be time-varying as well as allowing for different 
scenarios regarding length of SW exposure. 
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There are different facets of SW that we would have liked to have captured. While we had 
data on years of SW exposure, we were not able to capture intensity of SW, i.e. number of 
shifts per month. A strength was that we had a measure of NW; however, we were not 
able to measure whether the NW was permanent or part of a rotational work schedule, 
i.e. the shift system. This is a limitation of not only Study III and Study IV but also of 
previous studies82, 83, 132, 146 that have not been able to consider all these different pieces 
of SW in relation to late life cognition or risk of dementia.  
 
8.4 ETHICAL CONSIDERATIONS 
Ethical considerations in medical research are taken seriously in Sweden; the right to 
be informed in understandable terms about the research one is participating in, as well 
as the right to decline to participate in research is written in Swedish Law. In all STR 
sub-studies, informed consent was obtained from participants. With regards to use of 
register-based data, informed consent is not required, but approval is needed from the 
ethics committee. Ethical considerations of using register data in medical research has 
been explored at length,85 with the conclusion that register-based research is of 
important value to society, and that the benefits of its use outweighs the potential harm.  
Ethical permits obtained for each of the studies: 
Study I – Dnr 00-132 and 97-051 
Study II – Dnr 00-132 and 97-051.  
Study III – Dnr 00-132 and 97-051 
Study IV – Dnr 84:61, 98-319, and 2010/657-31/3 
When working with large amounts of data as one does in epidemiological research, 
ethical considerations are mainly concerned with the ensuring integrity of participants 
and data security. Great care is taken in protecting the privacy of study participants. 
Data that is available to researchers do not include the PIN, names, addresses or any 
other personal identifiers. Findings based on these data are presented as aggregate 
findings (i.e. characteristics of the group and not of the individual). Additionally, for 
each project in this thesis, access to data and documentation is restricted to only those 
involved in the project. 
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9 IMPLICATIONS FOR PRACTICE AND FOR FUTURE 
RESEARCH 
The work described in this thesis has provided additional pieces of understanding on 
the role of sleep and SW in cognitive health later in life, but there are still pieces of the 
puzzle missing.   
 
Regarding the association between chronotype and dementia, there have only been two 
studies—Study I and one other121—that have investigated and demonstrated the 
connection between delayed habitual rising155 or rhythms121 with subsequent risk of 
dementia; thus, more studies are called for.  
 
Collectively, Study I and previous research findings offer compelling evidence—
epidemiological and otherwise—of short sleep conferring risk of dementia. We hoped 
to dig deeper, but due to lack of data, we were unable to answer the question of whether 
short sleep interacted with genes influencing dementia, or if there was genetic overlap 
between the two. This is important for understanding the mechanisms underpinning 
the association which could serve as a basis for future research or interventions. So 
although the studies in this thesis were based on large samples, future studies with larger 
samples, using quantitative genetic models, are needed to further investigate if short 
sleep and risk of dementia share underlying genetic etiology, or if short sleep potentiates 
genes influencing dementia liability.  
 
In a clinical setting, an assessment of sleep habits among older aged patients would be 
useful, especially as part of a cognitive screening protocol. Short sleepers may be 
offered interventions such as cognitive behavioral therapy for insomnia (CBT-I).156 
Patients with habitually long sleep (beyond 9 hours) or late rising times (later than 
8AM) may give indication of underlying health issues or prodromal features of 
neurodegenerative disease, and thus allow for appropriate treatment earlier on and 
potentially delay cognitive impairment. 
 
A number of studies of sleep and subsequent dementia risk have been examined in study 
populations where participants are aged 65 and above. The literature would benefit from 
prospective studies following adults at an earlier age on sleep habits, SW status, and 
cognitive and dementia development. As a complement to subjective measures of sleep, 
objective measures would offer deeper insight, but of course objective measures of sleep 
on a large scale is understandably hard to come by. 
 
In contrast to sleep, there is very little in the literature on SW and its impact on later life 
cognition. Study III and Study IV have only scratched the surface of this topic, and further 
studies are needed to elucidate the long-term effect of SW on pathological versus non-
pathological cognitive aging. The interesting interaction finding of SW and APOE 4 with 
respect to dementia incidence in Study III needs to be replicated in future studies. The 
age at which SW was performed may contribute to an adverse cognitive profile, and this 
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detail has not yet been examined. Additionally, the possibility of cohort effects influencing 
SW could suggest that the burden of dementia is even greater in lower-income aging 
populations where occupational health and safety standards are poorly enforced.  
There is still work to be done, and the practical implications for cognitive health in old 
age arising from epidemiological research—past, present and future—on the role that 
SW and sleep plays—as a contributory factor or marker—are considerable.  
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10 CONCLUSIONS 
With the help of unique data sources and a variety of epidemiological methods, the 
studies within this thesis highlight the role of sleep and SW in late life cognition and 
dementia, specifically: 
I. Short and long TIB as well as late rising time among older adults are associated 
with increased incidence of dementia. Long sleep and delayed rising may be 
markers of prodromal dementia, whereas short TIB fits the role of a risk factor 
for dementia. 
II. Long TIB and late rising, while associated with greater dementia and AD 
incidence, does not potentiate genetic influences of dementia and AD liability.  
III. Midlife SW, including NW, compared to day work is associated with elevated 
dementia incidence. Additionally, a modest dose-response association is shown, 
with longer duration of SW and NW predicting higher dementia risk. 
IV. Normative cognitive aging differs in extent between individuals, but history of 
midlife SW does not appear to explain differences in rate of cognitive change in 
later life.  
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